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Abstract 
Magnesium and its alloys are promising candidates to be employed as a new generation 
of biodegradable metals in orthopaedic applications. However, the rapid degradation rate of 
magnesium alloys in the physiological environment has prevented their widespread application 
in medicine. The main objective of this thesis was to develop surface modification strategies that 
control the degradation rate of magnesium alloys in physiological environments and to provide 
an accurate assessment and evaluation of their biocompatibility in vitro. The overall thesis is 
composed of three individual projects.   
The first project was to develop an accurate method to test the in vitro biocompatibility of 
magnesium alloys. In this study, the CyQUANT assay was used to quantitatively evaluate the in 
vitro biocompatibility of Mg AZ31 alloy by both direct and indirect methods. The results 
demonstrated that the CyQUANT assay provides a more complete assessment of the overall in 
vitro biocompatibility of biodegradable metals by combining both direct and indirect analyses.    
In the second project, a multilayer coating consisting of a sol-gel silica layer followed by 
a mesoporous silica layer and finally a layer of calcium phosphate was developed. Surface 
characterization showed that a uniform and stable multilayer coating was successfully deposited 
on the Mg AZ31 alloy. In vitro characterization of the coatings confirmed this surface 
modification strategy significantly decreases the degradation rate of the magnesium alloy and 
that it is not cytotoxic.  
Superhydrophobic surfaces decrease the corrosion rate of magnesium alloys, however, 
cell adhesion is inhibited. In the third project, a superhydrophobic magnesium alloy surface was 
modified with the cell adhesive molecule, MAPTrix-F-RGD and the influence of this surface 
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modification on cell adhesion was studied. The results demonstrate that although the MAPTrix-
F-RGD molecule was successfully immobilized to the superhydrophobic magnesium alloy 
surface, cell adhesion was not improved. The complex surface topography of the 
superhydrophobic Mg AZ31 surface may be responsible for the observed cell behavior.  
This thesis demonstrates that surface modification can be used to simultaneously control 
both the biodegradation rate and the biocompatibility of magnesium and its alloys, making these 
materials promising candidates for orthopaedic applications. In addition, it has been 
demonstrated that cell quantification assays based on the fluorescence of cyanine dyes are an 
excellent method for in vitro testing of these materials in direct contact with cells. 
Keywords 
Magnesium alloys, biodegradation, biocompatibility, surface modification, mesoporous 
silica, calcium phosphate, direct method, indirect method, CyQUANT assay, cell adhesion, 
cytotoxicity, superhydrophobic surface, fibronectin mimetic  
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Chapter 1  
1 Introduction 
State-of-the-art orthopaedic surgical treatments depend greatly on the development of 
biomaterials used for the fixation of fractures and joint replacements. Biomaterials are artificial 
materials used in medical applications for the replacement and treatment of diseased or injured 
tissue in different parts of the body; some examples include cardiovascular, dental and 
orthopaedic implants [1]. Biomaterials provide a significant improvement to the health and well-
being of humans. The human body may be subjected to various painful injuries such as strains, 
sprains, dislocations and fractures. Fractures are a break in the bone due to excessive external 
forces acting on the bone that are greater than the strength of the osseous tissue. The risk of 
fracture is highly dependent on age, gender, bone strength and the overall health of an individual 
[2].  
Every year, millions of people suffer from bone fractures and degenerative joint diseases. 
The type of treatment required depends on the level of damage. In the case of degenerative joint 
diseases, bone replacement is typically needed. These permanent implants, such as artificial hips 
and knees, replace damaged tissue and therefore have to remain intact in the body. For this 
reason, they are most often manufactured from inert materials such as titanium, titanium alloys 
and cobalt-chrome alloys. In the case of fracture fixation, metallic pins, screws and plates may be 
surgically implanted to provide external support for the damaged bone tissue while it heals. This 
type of orthopaedic implant is meant to provide temporary support to prevent the treated bone 
from moving during the healing process [3].   
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The most commonly used materials for bone fracture fixation are typically metals such as 
stainless steel and titanium alloys. These materials were chosen due to their flexibility, high 
strength and excellent corrosion resistance [4]. However, a second surgery is needed to remove 
these temporary implants after tissue healing. This leads to potential re-damaging of the healed 
bone, discomfort for the patient and a significant cost to the health care system. An ideal 
temporary orthopaedic implant would provide the necessary mechanical strength during the 
initial stages after implantation but would gradually degrade and be replaced by new bone tissue 
as the patient healed. This would eliminate the need for a second surgery. Furthermore, the 
implant should produce non-toxic degradation products and degrade slowly enough that the 
implant maintains its mechanical strength until the bone tissue has healed sufficiently to provide 
load-bearing support [5]. 
1.1 Biodegradable Orthopaedic Biomaterials 
New biodegradable implants for fracture fixation may provide significant advantages 
compared to the permanent implants currently used by orthopaedic surgeons. As mentioned 
previously, the use of biodegradable materials for fracture fixation would eliminate the need of 
removal surgery. Instead, these implants would be dissolved, absorbed, or excreted in the 
biological media to allow the surrounding tissue to proliferate and integrate with the implant and 
finally replace it. However, these materials need to maintain their mechanical properties until the 
implant is no longer needed for support [6]. 
Various materials have already been identified as biodegradable biomaterials and most of 
them are polymers. However, biodegradable polymers do not stimulate bone regeneration and 
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their mechanical properties are different from natural bone; thus, they do not provide enough 
support to the damaged bone [4]. Therefore, metallic material are more suitable for load-bearing 
applications compared with polymeric materials due to their high mechanical strength and 
fracture toughness [6]. In recent years, biomaterials scientists have proposed biodegradable 
metallic implants composed of chemically reactive metals such as iron and magnesium. 
1.2 Magnesium as a Metallic Biodegradable Orthopaedic Biomaterial 
The first clinical report of magnesium as an implant material was by the physician 
Edward C. Huse in 1878 [7]. He successfully stopped bleeding in vessels on several patients by 
using magnesium wire as a ligature. Other early reports, proposed the use of magnesium and its 
alloys for a variety of potential medical applications including magnesium plates, wires and 
tubes [7]. However, the high degradation rate of these early magnesium materials was a major 
drawback to their use in orthopaedics. Therefore, many physicians preferred to use other metallic 
materials with high corrosion resistance such as stainless-steel alloys and titanium alloys since 
the problem of controlling the corrosion of magnesium had not been appropriately solved. 
Consequently, despite its potential, research on the use of magnesium as a biomaterial was 
temporarily abandoned [7,8]. In the last two decades, research in this area has been reinvigorated 
due the development of better magnesium alloys and its unique properties as a biodegradable 
biomaterial. Among these unique properties is the biodegradability through anodic dissolution 
that results in the release of non-toxic magnesium ions that can be easily excreted in the urine 
[9]. In other words, magnesium implants can be gradually absorbed and the degradation products 
readily excreted by the body [10]. In addition to its biodegradability in the human body, these 
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materials have mechanical properties that are similar to natural bone making them a promising 
alternative to stainless steel and titanium alloys. 
1.3 Biocompatibility of Magnesium in the Human Body 
The biocompatibility of a material is an important key factor for successful implantation.   
The term biocompatibility has been defined by Williams as "The ability of a material to perform 
with an appropriate host response in a specific application" [11]. It means that the material 
should be compatible with the living tissue; it should be non-toxic and should not cause any 
immunological rejection. 
Biocompatibility of metallic biomaterials is usually affected by corrosion processes in the 
human body. In metallic biomaterials, toxic metal ions (nickel, chromium, cobalt, etc.) are 
released in the body from corrosion and may lead to undesirable immune responses such as 
inflammation, cell apoptosis and other damaging tissue reactions. It was reported that exceeding 
the concentration limit of Cr (Co–Cr alloys), Nb, V and Ni (Ti-based) ions in the surrounding 
tissue or the body fluid may cause harmful tissue reaction. For example, Ni is an extremely 
cytotoxic, genotoxic, carcinogenic and mutagenic element [4]. Thus, these metallic implants do 
not have optimum biocompatibility.  
Magnesium differs from other metallic biomaterials by having excellent biocompatibility.  
In fact, magnesium is the fourth most abundant inorganic element in the human body. The 
average adult human body weighs around 70 kg and contains approximately 21-28 g of 
magnesium [12]; 50 percent of this total body magnesium is stored in the skeletal system. To 
maintain appropriate magnesium levels in the body, humans need to absorb between 300 to 400 
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mg of magnesium daily [12,13]. Moreover, magnesium is also essential to human metabolic 
functions such as DNA/RNA stabilization and it acts as a co-factor for more than 300 different 
enzymatic reactions [13].  
Magnesium influences many biological functions within the body and plays a very 
important role within the cell [13]. A number of studies demonstrate that divalent cations such as 
Mg2+ play a critical role in the remodeling and formation of bone tissue [4]. In addition, 
magnesium is one of the most important ions in the formation of the biological mineral phase, 
hydroxyapatite, on the surface of an implanted device. Some studies have reported that calcium 
phosphate can be formed on the surface of magnesium alloys exposed to both in vitro and in vivo 
environments [14]. This layer of calcium phosphate can form in direct contact with the 
surrounding tissue in vivo and can improve both the corrosion rate and the biocompatibility of 
magnesium in physiological solutions. 
Moreover, it was reported that the presence of magnesium on orthopaedic implants could 
enhance osteoblastic cell adhesion and promote ideal osteogenesis. An in vitro study by Pietak et 
al. has shown that magnesium-based substrates can promote bone cell attachment on the implant 
surface [15]. Another article by Li et al. has shown that Mg-1Ca alloy did not induce toxicity to 
cells and had high activity of osteoblast and osteocytes around the alloy in an in vivo experiment 
[16]. 
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1.4 Physical and Mechanical Properties of Magnesium in Comparison to 
Natural Bone 
Materials used in orthopaedic applications should have very similar mechanical 
properties as natural bone. Metallic materials play an important role as biomaterials to assist with 
the repair of bone tissue that has been damaged or diseased. Commonly implanted metallic 
biomaterials include stainless steel, titanium and cobalt-chromium-based alloys [4]. However, 
most of the metallic biomaterials show significantly higher mechanical properties in comparison 
to natural bone. Biodegradable implants with the highest mechanical properties do not represent 
the best performance for orthopaedic application as this mismatch results in implant failure due 
to the stress shielding effect [17]. The stress shielding effect is the reduction in the density of 
bone tissue due to the removal of the normal stress on the bone after implantation. The bone in a 
healthy person will remodel in response to an applied load. Therefore, the bone will become 
weaker if the loading on bone decreases due to the difference in the stiffness between natural 
bone tissue and the implant material [18]. For example, a huge difference in elastic moduli 
between these metallic materials and natural bone causes the stress shielding effect. Therefore, a 
metallic biomaterial with lower elastic modulus is desired to effectively reduce the stress 
shielding effect and thereby improve bone remodeling. 
Magnesium has physical and mechanical properties that are more similar to natural bone 
than traditional metallic implant materials. A brief summary is given in Table 1.1 which shows 
that the density of pure magnesium is approximately 1.74 g/cm3, it is 2.5 times less dense than Ti 
alloy and 4.5 times less dense than steel making it the structural metal with a density closest to 
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that of human bone tissue (1.8 g/cm3). The elastic modulus and compressive yield strength of 
magnesium are also the same order of magnitude as that of natural bone (Table 1.1) [6]. These 
similarities to natural bone should help in reducing or avoiding the stress shielding effect thus 
enhancing stimulation and remodeling of the bone tissue. Therefore, these mechanical properties 
contribute to making magnesium an ideal biomaterial for fracture fixation devices that provide 
good mechanical stability in the early stages of healing. 
Table 1.1: Summary of the Physical and Mechanical Properties of Metallic Materials in 
Comparison to Natural Bone [6]. 
Properties 
 
Natural 
bone 
Pure 
magnesium 
Ti alloy Co-Cr 
alloy 
Stainless steel 
Density (g/cm3) 1.8-2.1 1.74-2.0 4.4-4.5 8.3-9.2 7.9-8.1 
Elastic modulus 
(GPa) 
3-20 41-45 110–117 230 189-205 
Compressive yield 
strength (MPa) 
130-180 65-100 758-1117 450-1000 170-310 
Fracture toughness 
(MPa/m1/2) 
3-6 15-40 55-115 N/A 50-200 
 
1.5 Challenges for Using Magnesium as a Biodegradable Implant 
The performance conditions of an ideal biodegradable magnesium-based material for 
orthopaedic applications should properly match the injured tissue reconstruction and healing 
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process to provide temporary mechanical support and then completely dissolve in the human 
body with an appropriate degradation rate. For a biodegradable material, as the degradation 
proceeds, the degeneration of mechanical integrity of the implant is expected [19]. This is 
illustrated in the Schematic Diagram (1.1) that shows the biodegradation and mechanical 
integrity of an ideal biodegradable implant during bone healing process. In general, the healing 
process of bone fracture occurs in three stages: inflammation, repair and remodelling [4,19]. The 
first stage of healing is inflammation when the immune system responds to the foreign body, this 
stage lasting for 1 to 7 days. In the repair stage, the implant integrates with new bone tissue as 
regeneration of tissue occurs over a period of 3-4 months depending on the fracture position and 
type. Finally, the remodelling stage is the longest in the healing process of the bone fracture. It 
involves regeneration and remodelling of the new bone by replacing the woven bone by cortical 
bone. This stage takes several months to years to be completed [19,20]. Unfortunately, most of 
the magnesium based orthopaedic implants degrade prior to complete healing causing implant 
failure.  
Studies have shown that magnesium is highly degradable in both acidic solution and at 
the neutral pH conditions typically observed in the physiological environment [21]. Therefore, 
the high degradation rate of magnesium in the human body not only impacts the tissue healing 
process but can also lead to the loss of the mechanical integrity of the material implant causing 
the occurrence of a second fracture. As magnesium and its alloys have received much attention 
for biodegradable orthopaedic applications, several biodegradable Mg alloys have been 
developed but most of them are inadequate for medical implants due to a rapid degradation rate 
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and loss of mechanical integrity before the surrounding tissue has sufficiently healed. 
Magnesium alloy implants should maintain their mechanical properties for at least three months 
while the bone tissue healing occurs [20]. Therefore, it is important to control the degradation of 
magnesium implants after implantation into the human body as the rate of magnesium 
degradation is normally too fast in the initial stage. 
 
Schematic Diagram 1.1: The Schematic Diagram of the Biodegradation and Mechanical 
Integrity of Ideal Biodegradable Implants During the Bone Healing Process. Adapted from 
[19]. 
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1.6 Degradation Process of Magnesium 
The mechanism of degradation of metallic biomaterials occurs through corrosion of the 
materials by reaction with its environment under the influence of chemical, physical and 
electrochemical factors. The overall corrosion process of metallic materials 
involves electrochemical reactions to produce oxides, hydroxides and hydrogen gas. The rapid 
corrosion rate of magnesium in the physiological environment is the major problem that has 
limited the widespread use of magnesium alloys as biomaterials.  
In aqueous solution, the corrosion reaction of pure magnesium proceeds by an 
electrochemical reaction with water as shown in Reaction Scheme 1.1. This reaction involves the 
anodic dissolution of magnesium and cathodic reduction of water. The products of this 
reaction are hydrogen gas, magnesium ions and hydroxide ions, leading to an increase in pH and 
ionic strength of the surrounding solution. These electrochemical reactions result in the 
formation of a magnesium hydroxide layer on the surface of magnesium that acts as a barrier 
layer between the magnesium substrate and the aqueous solution slowing the electrochemical 
reaction across the magnesium surface. 
Reaction Scheme 1.1: General Corrosion Mechanism of Magnesium. 
Anodic reaction:  Mg(s) → Mg2+ (aq) + 2e- 
Cathodic reaction:  2H2O (l) + 2e
- → 2OH-(aq) + H2 (g) 
Product formation:  Mg2+ (aq) + 2OH
-
(aq) → Mg(OH)2 (s) 
Overall reaction:  Mg(s) + 2H2O (l) → Mg(OH)2 (s) + H2 (g) 
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However, the physiological solution is a highly corrosive environment for magnesium 
and its alloys due to the presence of dissolved oxygen, proteins and electrolyte ions such as 
chloride [8,19]. These conditions play an important role in the accelerated corrosion of 
magnesium in body fluids. In the physiological environment, chloride ions react with the passive 
magnesium hydroxide layer leading to the formation of highly soluble magnesium chloride layer 
according to Reaction Scheme 1.2. Therefore, the underlying magnesium substrate is continually 
exposed to the corrosive media resulting in the occurrence of pitting corrosion of the magnesium 
substrate. Moreover, the corrosion in body fluids is influenced by various factors including pH, 
concentration and the types of ions, protein adsorption on orthopaedic biomaterials and influence 
of the biochemical reactions of surrounding tissues [4].      
Reaction Scheme 1.2: Influence of Anions. 
Mg(OH)2 (s) + 2Cl
- (aq) → MgCl2 (aq) + 2OH- (aq) 
1.7 Types of Corrosion 
There are two primary types of corrosion that can affect magnesium and its alloys in the 
physiological environment including pitting corrosion and galvanic corrosion. 
1.7.1 Pitting Corrosion 
Pitting corrosion is usually observed in the physiological environment due to the presence 
of aggressive ions such as chloride ions. Pitting is a type of localised corrosion associated with 
the breakdown of the hydroxide passivation layer in a corrosive environment. It is a serious type 
of corrosion, since the surface pits are difficult to detect due to the formation of corrosion 
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product [4]. After the pitting begins, magnesium materials can be corroded in a very short period 
of time resulting in reduction of the load bearing capacity in the case of orthopaedic applications 
[4,20]. Moreover, pitting corrosion increases the localised stress that may lead to the formation 
of cracks. The presence of stress corrosion cracking (SCC) and metal fatigue cracks in the pits 
can lead to an implant failure [4].  
1.7.2 Galvanic Corrosion 
Galvanic corrosion occurs when two dissimilar metals come in contact with each other in 
the same electrolyte and is due to the difference in electrochemical potential between these 
metals. Thus, the less noble metal acts as an anode which corrodes rapidly and produces by-
products in the surrounding area [4,17].  
Galvanic corrosion is the primary issue for magnesium and its alloys in orthopaedic 
applications due to the presence of different alloying elements and phases [17]. Magnesium is a 
highly active metal and always acts as an anode when it comes in contact with other metals 
(cathode) resulting in galvanic corrosion. Consequently, Mg and its alloys rapidly corrode. In 
addition, galvanic corrosion can result from the presence of impurities or intermetallic elements 
in the Mg matrix [4,20]. 
1.8 Biodegradation Process on Biocompatibility of Magnesium and Cell 
Responses 
As it was discussed in the previous section, biocompatible material should not cause cell 
death, chronic inflammation or damage any cellular or tissue functions. Biodegradable 
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orthopaedic implants not only have to be biosafe in terms of cytotoxicity, they also need to have 
appropriate biodegradation rates and successful integration within the bone by interaction with 
the living tissue to guarantee the biocompatibility of the implant. 
Osteoconduction and osseointegration are important factors for the biocompatibility of 
orthopaedic materials in the human body. Osteoconduction and osseointegration of the bone both 
depend on the response to a foreign material [22]. Osteoconduction is the process by which bone 
cells grow on the surface of the orthopaedic implant. Osseointegration is the stability of an 
implant achieved by a direct contact between living bone and implant without the growth of 
fibrous tissue at the bone-implant interface. Osseointegration of the implant depends on 
osteoconduction. If a material is too toxic to allow bone cell attachment on the surface, meaning 
that the material is not osteoconductive, it will not osseointegrate leading to the long-term poor 
performance of the implant long term [22].  
Bone tissue is formed of four different types of cells: osteoblasts, osteocytes, bone lining 
cells and osteoclasts. Osteoblasts are located on the bone surface and contribute to bone 
formation and mineralization. Therefore, biocompatibility of magnesium is dependent on the 
behaviour of osteoblasts and their adhesion and proliferation on the implant surface [23].  
To date, many studies have investigated the effect of magnesium on bone formation. It 
has been shown that magnesium has a significant effect on osteoblastic cell differentiation which 
indicated its effect on the acceleration of bone healing [17]. The biodegradation of magnesium 
implants in the human body led to the release of Mg2+ ions to surrounding tissue which resulted 
in stimulation of the local cells to form bone [17]. However, the rapid degradation of Mg alloy 
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implants leads to the release of high concentrations of Mg2+, OH–, H2 and ions of alloying 
elements that negatively affect the cell viability and, therefore, its biocompatibility [8]. Although 
previous studies demonstrated that the hydrogen gas can be tolerated by human body, high 
amounts of hydrogen gas production within the implant environment and an increase in the local 
pH both have significant effects on the surrounding tissues [8,17]. Consequently, it can result in 
complications in the healing process. 
Therefore, it is essential to increase the corrosion resistance to extend the lifetime of 
magnesium in the human body, giving the body enough time to deal with the biodegradation 
products and maintain its mechanical integrity until healing occurs. In addition, improving the 
biocompatibility of the magnesium surface can be considered to accelerate the healing process 
and regenerate new bone tissue around the magnesium implant. 
1.9 Improving the Performance of Magnesium for Orthopaedic Application 
The definition of biodegradable metals was given for the first time by Zheng and 
colleagues in 2014 as “Biodegradable metals (BMs) are metals expected to corrode gradually in 
vivo, with an appropriate host response elicited by released corrosion products, then dissolve 
completely upon fulfilling the mission to assist with tissue healing with no implant residues” 
[19]. This means the major metals used in the composition of biodegradable biomaterials should 
be absorbed by the human body and demonstrate appropriate degradation rates in the human 
body matching the bone healing process. Thus, it is essential to increase the corrosion resistance 
to maintain its mechanical properties and enhance the biocompatibility to ensure the 
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osteointegration and osteoconduction of the implant and, therefore, regeneration of new bone 
before degradation. 
In spite of the advantageous properties that magnesium metal exhibits, the commercially 
available pure metal cannot provide either the appropriate mechanical properties or corrosion 
resistance for orthopaedic application. There are currently a number of strategies that have been 
investigated to obtain suitable degradation rates and provide appropriate mechanical properties, 
as well as improve the biocompatibility and the osteointegration potential of magnesium for 
orthopaedic biomaterials. Some of these strategies include using high purity alloys, addition of 
new alloying elements, surface modification and deposition of protective coatings.  
1.10 Alloying 
Magnesium alloys are of a particular interest for many applications since they have 
enhanced mechanical properties and corrosion resistance in comparison to the unalloyed metal 
[24]. An alloy is a mixture of metals or a mixture of a metal and other elements. Alloys of Mg 
can be binary, ternary or more [6]. It is essential to choose an appropriate element which can 
enhance mechanical properties and corrosion resistance but is also non-toxic to guarantee the 
biocompatibility of the implant. Therefore, biomaterial scientists recently focussed on 
investigating biologically safe magnesium alloys containing non-toxic elements such as Ca, Zr, 
Zn, Mn, Sr, Li, Sn, Si, Bi, Cd, Ag [6,25]. The composition of various magnesium alloys is given 
in table 1.2. 
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Table 1.2: Composition of Various Magnesium Alloys 
Magnesium alloy  Nominal Composition (weight %) 
Mg AZ31 3% Aluminium, 1 % Zinc, Balance Magnesium 
Mg AZ61 6% Aluminum, 1% Zinc, Balance Magnesium 
Mg AZ91 9% Aluminum, 1% Zinc, Balance Magnesium 
Mg ZK40 4% Zinc, less than 1% Zirconium, Balance Magnesium 
Mg-6Zn-1Ca 6% Zinc, 1% Calcium, Balance Magnesium 
Mg-0.5Ca 0.5% Calcium, Balance Magnesium 
Mg-1Ca 1% Calcium, Balance Magnesium 
 
For instance, Ca is a well-known alloying element for accelerating bone growth and 
improving corrosion resistance [17,26,27]. Li et al. developed binary Mg-Ca alloys with different 
amount of Ca. Alloys of high Ca content were shown to be very brittle which was detrimental for 
their mechanical properties. However, alloys with low content (1 wt% of Ca) showed a slow 
degradation rate in vitro and in vivo. Also, the study indicated that Mg-1Ca alloys were not 
cytotoxic to cells. This study indicated that the mechanical properties and biocorrosion resistance 
of Mg-Ca alloys are adjustable by controlling Ca content [27]. Another study by Rad et al. 
suggested Mg-0.5Ca alloy as a great candidate for biodegradable implants due to its high 
corrosion resistance [28]. Sr is also considered one of the promising biocompatible alloying 
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elements in magnesium alloys. Studies showed that Sr significantly enhances the osteoblastic 
activity and bone formation in vivo, which improves its biocompatibility [17,27,29]. Li et al. 
studied the biodegradation of Mg-Zr-Sr alloys in vitro and in vivo. The study demonstrated that 
addition of less than 2% Sr significantly decreased the corrosion rate for Mg-Zr-Sr and Mg-Sr 
alloys; an improvement in biocompatibility was also observed [29].  
Zn is one of the common alloying elements for magnesium. The presence of zinc in 
magnesium alloys can increase the tolerance limits and reduce the effect of impurities. Also, it 
increases strength without decreasing flexibility [6,17]. Studies showed that the presence of 6% 
Zn in magnesium alloys decreases the corrosion rate of the material [30]. In addition to 
improving the mechanical properties and the corrosion resistance of magnesium, it was also 
demonstrated that the presence of Zn in magnesium alloys enhances osteoblastic cell 
proliferation. A study by Hong et al. further indicated that ZK40-Mg and AZ31-Mg alloys 
enhance cell proliferation compared to pure Mg [31].  
Aluminum is often used as an alloying element for magnesium to enhance the corrosion 
resistance. The corrosion rate of magnesium alloys decreases rapidly with increasing aluminum 
content due to a decrease in the impurity level with increasing Al content and the formation of 
the more noble β-phase acts as a barrier to the progression of the corrosion attack [32]. However, 
the presence of high concentrations of aluminum can be considered toxic for humans. Therefore, 
it is highly recommended to use aluminum with low concentrations in biomaterial applications. 
Even though the biocompatibility of aluminum is limited, it seems to be an acceptable alloying 
element for magnesium in the human body [17]. An in vivo study performed by Witte et al. 
18 
 
 
 
indicated that alloyed Mg with different concentrations of Al did not show any cytotoxic or 
neurotoxic effects up to 9 wt% of Al and the osteoblastic activity around the implant was 
increased with increasing amount of Al up to 9 wt%. Therefore, the small amount of Al ions that 
are released during the degradation of magnesium can be tolerated by the human body [33]. 
AZ31, AZ61, and AZ91 are common Mg-Al-Zn alloys with reasonable corrosion rates. 
Huang et al investigated the in vivo degradation behavior of a Mg-Al-Zn (AZ31) alloy implanted 
into rabbits. After a nine-week period, formation of a thin layer of calcium phosphate was shown 
around the implants and the in vivo degradation rate of Al-Zn containing Mg alloys was slower 
than that of pure Mg [34]. AZ31 is the alloy that was used in this project, A and Z correspond to 
aluminum and zinc, which are present in the alloy with concentrations of 3 % and 1 % by mass 
respectively. This alloy has a good combination of suitable mechanical properties, corrosion 
resistance and low concentration of aluminum. 
 
1.11 Surface Modification 
Despite of the possible alloying process of magnesium to improve its degradation rate 
and mechanical properties, magnesium alloys may remain very reactive in physiological 
environments. Thus, surface modification is an additional way to provide an optimum 
biodegradable orthopaedic implant. Surface modification is one of the most effective ways to 
simultaneously control the biodegradation rate and improve the surface biocompatibility of 
magnesium alloys. 
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To fully understand the impact of surface modification, it is very important to have a 
good knowledge of the influence of surface characteristic on the orthopaedic implants and their 
cell responses. 
 Surface Characteristics 
Orthopaedic implants not only have to be non-toxic and stable in terms of cytotoxicity 
and degradation, they also have to match the structure of bone to enhance the interaction between 
the implant surface and the living tissue.  
The hierarchical structure of human bone should be highly considered in orthopaedic 
biomaterial designs to successfully replace tissue in the bone. Human compact bone is a 
composite natural material with macro to nano scale features in a hierarchical structure [35]. 
Therefore, to achieve a high grade of compatibility with host tissue, this range of scale should be 
taken into account. 
Understanding surface characteristic of the implants is key in order to achieve excellent 
biocompatibility of the orthopaedic biomaterial with the host tissue. Moreover, the biomaterial 
surface is a major factor influencing the success or failure of the implantation process due to the 
direct contact of the implant surface and the host tissue. 
 Surface Roughness 
Surface roughness is a significant factor for the osseointegration rate and biomechanical 
fixation of orthopaedic implant to bone [35]. Several studies have shown that increasing the 
surface roughness at the micro-scale range improves the rate of new bone formation as a result of 
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an increase in protein adsorption and cellular activity [17,35]. Zareidoost et al. studied the 
relationship of implant surface roughness and cell response and established that osteoblastic cell 
adhesion and proliferation are correlated to surface roughness. It was found that the cell 
viability and proliferation on rough surfaces etched with HCl-HF-H3PO4 was higher than on 
the polished surfaces [36]. 
In particular, in a study of magnesium alloys, a significant increase in bone cell adhesion 
was observed by increasing the surface roughness of a magnesium alloy from 3.40 nm to 23.40 
nm through deposition of a rough and dense layer of HA/TiO2 composite coating on magnesium 
alloys [37]. 
Thus, mimicking the bone surface with a combination of macro, micro and nano scale 
roughness on the implant surface may enhance osseointegration of the implant due to an increase 
in hydroxyapatite deposition and cellular activity. Various methods are employed to create such 
microstructural surface features including blasting, acid-etching, anodization and plasma-
spraying [35]. 
 Porous Structure  
Pore size and morphology have a considerable impact on cell attachment and 
proliferation. It was demonstrated that the size and structure of the pore play a very important 
role in designing orthopaedic implants [17]. Studies have shown that pores with a hexagonal 
structure increase cell attachment more than the pores with spherical structure. However, it was 
found that the mechanical properties of implants decrease with increasing the pore size resulting 
in brittle behavior [38].  
21 
 
 
 
Due to the influence of porous structures on mechanical properties, a significant concern 
for orthopaedic applications, porous materials have been proposed as a coating on implant 
surfaces to improve the cell attachment and proliferation resulting in successful osseointegration 
of the orthopaedic implant [39,40,41]. Moreover, porous surface implants have been effectively 
used as a drug delivery coating by incorporation of drugs into the pores [42-43]. 
 Wettability 
Wettability (hydrophobicity/hydrophilicity) is one of the parameters affecting the 
biological response of the biomaterial. In general, wettability can be influenced by four primary 
surface characteristics: roughness, chemical composition, surface energy, and heterogeneity. The 
surface wettability of biomaterials can be controlled by surface modification techniques, such as 
ion implantation, surface coating, chemical etching, and laser surface modification techniques 
[44].   
Hydrophilic surfaces typically enhance cell adhesion on the implant surface [45]. A study 
by Lim et al. detected the effect of the surface wettability of biomaterials on the osteoblast 
response by producing model substrates with various water contact angles ranging from 0o to  
120o.  They observed that human osteoblastic cells showed a strong positive correlation in cell 
adhesion and proliferation with biomaterial surface wettability. The osteoblastic cells exhibited 
greater adhesion and proliferation on hydrophilic surfaces than on hydrophobic surfaces [46]. 
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1.11.2  Type of Surface Modification 
Surface modification is primarily employed to controlling the degradation rate of 
magnesium alloys to maintain their mechanical properties and also to improve the surface 
biocompatibility of magnesium alloys for orthopaedic applications. These surface modification 
methods have been classified by Wang et al. into three types: chemical modification, physical 
modification, or a combination of these two methods [47,48].  
In recent years, researchers have focused on the combination of both chemical and 
physical modification. Generally, chemical modification is used as a pre-treatment to the 
physical process to improve adhesion. These double modifications on the substrate surface are 
more effective in improving the biodegradation resistance of substrates [47]. 
 Chemical Modification 
This type of modification is associated with the removal of the native oxide layer and its 
replacement with a new phase on the surface. The main advantage of this new phase is its 
improved adhesion to the substrate due to chemical bonding. Chemical surface modifications 
include: acid etching, alkaline treatment, fluoride treatment, anodization, and ion implantation 
[48].  
1.11.2.1.1 Acid Etching 
Acid etching could be adopted to remove the native oxide layer followed by creating 
uniform and compact layers leading to a lower degradation rate [47]. Gray-Munro et 
al. investigated the effect of acid etching as a pre-treatment on the degradation rate of the AZ31 
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magnesium alloy in SBF solutions. The magnesium alloys were immersed in a 90% (v/v) 
phosphoric acid solution at 55°C for 30 s, then neutralized in 100 g/L NaOH solution for 30 s. 
More homogenous and dense films of Mg3(PO4)2 layers were produced on the top of etched 
magnesium alloys compared with the unetched alloys leading to a significant decrease on the 
overall degradation rate in SBF (Simulated Body Fluids) [49].  
1.11.2.1.2 Alkaline Treatment  
A new passive layer is deposited on the surface of magnesium alloys after soaking in 
alkaline solutions leading to the formation of passive layer consisting of Mg(OH)2, MgCO3, and 
MgO [48]. It has been reported that an alkaline treatment by soaking the samples in 1 M NaOH 
has a significant effect on improving the degradation rate of magnesium due to the creation of a 
passive layer on the substrate surface [50-51]. Another study by Gu et al. investigated the 
influence of an alkaline heat-treatment on Mg-Ca alloy for controlling the biodegradation rate. 
The magnesium alloys were soaked in three different alkaline solutions (Na2HPO4, Na2CO3 and 
NaHCO3) for 24 h, and subsequently heat treated at 773 K for 12 h. The results indicated that the 
degradation rate of alkaline heat-treated Mg-Ca alloy in SBF were significantly decreased in 
comparison to the untreated alloy. Also, the cytotoxicity evaluation demonstrated that none of 
the alkaline heat-treated Mg-Ca alloys were cytotoxic to L-929 cells [52]. 
 Physical Modification 
Physical modification, also called physical coating can be employed by various strategies 
to create protective coatings on the Mg substrate. These types of coatings provide a physical 
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barrier between the metal and the corrosive environment. The deposition of a coating can also 
improve the biocompatibility and osteointegration of an implant [8,47,48]. Examples of physical 
surface modification include sol-gel processes, biomimetic methods (calcium phosphate and 
superhydrophobic coating) as well as multifunctional coatings. 
1.11.2.2.1 Sol-gel Coating 
The sol-gel process is an environmentally friendly method. It is one of the most popular 
methods to prepare a protective barrier coating. Sol-gel coatings have shown great chemical 
stability, oxidation control and improved corrosion resistance for different metal substrates such 
as aluminum, copper, steel, magnesium and their alloys. The sol-gel process has attracted a great 
deal of attention in the fields of ceramics, polymer chemistry, organic and inorganic chemistry 
and also plays an essential role in the production of novel organic-inorganic hybrid materials 
[53].  
The sol-gel process involves the synthesis of an oxide network through reactions of the 
precursor solution in a liquid. The overall sol-gel process consists of two chemical reactions: the 
first is a hydrolysis reaction and the second is a condensation reaction. The hydrolysis reaction 
produces the sol, while the condensation reaction forms a gel on the substrate producing a thin 
film. The coating deposited through the sol-gel process is influenced by the initial reaction 
conditions such as pH, temperature, molar ratio of water to precursor solution and solvent 
composition. For instance, synthesis of the coating at high temperature leads to a porous, 
nanocrystalline coating with a controlled microstructure [4,19].  
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Hu et al. prepared a nano TiO2 coating on AZ31 by the sol-gel method and investigated 
the relationship of the degradation rate of Mg alloy with the annealing temperature and time. The 
results indicated that the degradation rate increased with the annealing temperature higher than 
350 °C as the size of nano-spherical TiO2 particles of the coating increased and led to an 
increased degradation rate. On the other hand, the degradation rate was decreased gradually by 
the prolongation of the annealing time. It was concluded that the best improvement in 
degradation rate was obtained when the sol-gel coated samples were annealed at 250 °C for 3 h 
[54].  
Organosilane coatings have also been employed as protective and biocompatible coatings 
on Mg alloy for orthopaedic applications. There are several advantages of using organosilanes as 
protective barrier coatings such as its hydrophobic Si-O-Si networks, lower galvanic reactions 
with Mg, greater adhesive ability, easy chemical modification and low cytotoxicity [4]. Gaur et 
al. developed a sol-gel silane coating on Mg alloy (Mg-6Zn-1Ca (wt%)) using a mixture of the 
silanes diethylphosphatoethyltriethoxysilane (DEPETES) and bis-[3-(triethoxysilyl)propyl] 
tetrasulfide (BTESPT) to improve the degradation rate of magnesium alloys. The in vitro 
biodegradation evaluation indicated that the silane-based sol-gel coating provided a significant 
decrease in degradation rate of the coated magnesium alloys as compared to the bare Mg alloy. 
The degradation protection of this coating was attributed to the formation of highly dense Si-O-
Si networks [55].  
26 
 
 
 
1.11.2.2.2 Calcium Phosphate Coating 
The orthopaedic implant should have a bioactive surface to bond directly with the bone 
tissue for successful osseointegration. Calcium phosphate coatings have been prepared on 
magnesium substrates with various techniques to deposit different types of calcium phosphate 
coatings including hydroxyapatite (HA), fluoridated hydroxyapatite (FHA), and brushite 
(DCPD). Calcium phosphate coating has been shown to improve both the bioactivity and the 
overall biocompatibility of implants [19]. 
Biomimetic calcium phosphate deposition is one of the most useful techniques 
investigated for coating the surface of orthopaedic implants. The biomimetic deposition 
technique is used to provide a bone-like apatite (calcium phosphate) on the surface of 
orthopaedic implants. Therefore, the surface becomes more bioactive resulting in improved 
osseointegration of the implant into the human bone [19,56]. The biomimetic process is based on 
simple chemical immersion techniques to produce calcium phosphate coatings on the substrate 
using different kinds of solutions such as SBF (Simulated Body Fluids). Cao et al. prepared a Ca-
P coating on AZ31 Mg alloys using the biomimetic method by immersing Mg alloys into 1.5 
times SBF (Simulated Body Fluids) at pH 7.4 and 37oC. The corrosion resistance and 
cytocompatibility of the biomimetic calcium phosphate coating was investigated. The results 
showed that the corrosion resistance of the biomimetic Ca-P coating Mg alloys was significantly 
improved compared to uncoated magnesium alloys. Moreover, the biomimetic coating showed 
no cytotoxic effects to the cells. Furthermore, additional modification of this coating through the 
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immobilization of the RGDC peptide into the biomimetic coating resulted in a significant 
enhancement of cellular responses [56].  
Additionally, calcium phosphate coatings have been widely prepared by electrodeposition 
techniques using the acidic Ca(NO3)2, NH4H2PO4, and NaNO3 electrolyte systems. Song et al.  
used an electrodeposition technique to develop three kinds of calcium phosphate coatings 
(brushite, hydroxyapatite and fluoridated hydroxyapatite). The degradation behavior and 
bioactivity of these coatings on magnesium alloys was investigated. The results showed that all 
these coatings decreased the degradation rate of Mg-Zn alloys compared to uncoated alloys. 
However, fluoridated hydroxyapatite (FHA) coating on magnesium alloy was more stable than 
the brushite DCPD and hydroxyapatite HA coatings as it remained intact after immersion in 
modified simulated body fluid (m-SBF) for one month. It was also shown that HA and FHA 
coatings improved the bioactivity and mineralization ability (formation of bone-like apatite 
layer) of a Mg-Zn alloy demonstrated by the higher Ca/P ratio of the precipitates compared to the 
DCPD coating [57]. 
1.11.2.2.3 Superhydrophobic Coating 
The development of a superhydrophobic surface is one of the most recent strategies to 
improve the corrosion resistance of Mg alloys. In general, superhydrophobic surfaces are 
surfaces with high water contact angles greater than 150° and low sliding angles that are smaller 
than 5°. Superhydrophobic surfaces have been employed for many special functions such as anti-
corrosion, self-cleaning, anti-bacterial, and water-repellent surfaces. Superhydrophobic surfaces 
can be obtained by various strategies such as wet chemical reaction, hydrothermal reaction, 
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electrochemical deposition, self-assembly, phase separation, electrospinning, sol-gel, and 
polymerization reactions [58].  
The best-known natural example of a superhydrophobic surface comes from the lotus 
leaf. The superhydrophobicity of the lotus leaf can be mimicked on man-made surfaces. This is 
generally accomplished through a two-step surface modification: the first step is to form a 
surface with a micro/nanostructured roughness. A thin hydrophobic layer is then deposited 
leading to an overall superhydrophobic surface [58,59].  
Zhang et al. fabricated a superhydrophobic surface on magnesium alloy AZ31 through 
combination of a hydrothermal treatment method to get the hierarchical rough structures and post 
modification with low energy stearic acid. This superhydrophobic surface had a water contact 
angle of 157.6°. The corrosion results in 3.5% NaCl showed that the superhydrophobic coatings 
significantly improved the corrosion resistance of the AZ31 alloy [59].  
In addition to their excellent corrosion resistance, superhydrophobic surfaces has been 
used in biomedical applications as a surface to control protein adsorption, cellular interaction, 
and bacterial growth [60]. 
Although superhydrophobic surfaces decrease the rapid degradation of magnesium 
alloys, the interaction between the cells and the implants is also reduced leading to a decrease in 
the ability of the implant to induce bone regeneration thus limiting its biocompatibility. 
However, there are very limited studies carried out in this area. Therefore, novel strategies need 
to be designed to improve the cell adhesion and proliferation of the superhydrophobic surface for 
the development of biodegradable orthopaedic implants. 
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1.11.2.2.4 Multifunctional Coatings 
To overcome the limitation of magnesium and its alloys for orthopaedic application, 
protective coatings can be used as a multifunctional implant coating that not only control the 
degradation rate of the implant but also offer improved biocompatibility. For example, barrier 
coatings loaded with bone growth factors to accelerate the healing process, or antibiotic drugs to 
prevent inflammation may be effective. The surface modification of barrier coatings through 
immobilization of biomolecules or cell adhesive ligands such as RGD surface may efficiently 
bio-mimic the natural extracellular matrix environment to enhance cell adhesion.  
Luo et al. developed a polymer coating on pure magnesium loaded with an anti-
inflammatory dexamethasone drug. The polymer coatings significantly improved the corrosion 
resistance of magnesium. In addition, the polymeric coating was successfully loaded with 
dexamethasone which may control the inflammatory tissue response to Mg implants during 
implantation. Therefore, using a polymer coating loaded with a drug can improve both the 
degradation rate and biocompatibility of magnesium [61].  
Moreover, Yang et al. investigated the effect of covalent attachment of RGD peptides 
onto AZ31 magnesium alloy surfaces using mixed organosilane coatings to improve the 
corrosion resistance. This study demonstrated an increase in both cell adhesion and proliferation 
onto the magnesium alloys by immobilization of RGD peptides on the protective coating [62]. 
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1.12 Conclusions 
In this literature survey several strategies have been proposed for coating magnesium and 
its alloys in order to achieve the required improvements for successful implementation of these 
materials as a mainstream biomaterial. These various coating strategies have shown lowered 
corrosion rates as well as enhanced bioactivity and biocompatibility, making magnesium and its 
alloys promising candidates to be used as biodegradable biomaterials in orthopedic applications. 
However, future studies are also recommended to design the optimal magnesium implant 
for a biomedical application. In order to design materials for orthopaedic applications, not only 
the degradation rate of magnesium must be controlled, but also the mechanical properties and 
biological behaviours such as cell attachment, cell proliferation and cytocompatibility must also 
be investigated. 
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Chapter 2  
2 Objectives 
Conventionally used metallic biomaterials such as stainless steel and titanium alloys 
often result in stress shielding and metal ion release after implantation. Moreover, a secondary 
surgery may be necessary to remove the implant after tissue healing. Biodegradable metallic 
materials that can provide the required stability during the initial stages of healing and promote 
tissue regeneration as they degrade would eliminate both the toxic corrosion products associated 
with traditional metallic implants and the need for a second surgery. The innate biodegradation 
of magnesium metal makes it and its alloys suitable candidates for biodegradable materials due 
to their excellent biocompatibility coupled with outstanding physical and mechanical properties 
that are similar to natural bone. However, the rapid degradation rate of magnesium and its alloys 
in the physiological environment has restricted their widespread application in the biomedical 
field since uncontrolled degradation could result in failure of the implant due to the loss of 
mechanical integrity. In addition, surface modifications that can promote cell adhesion and 
proliferation are of interest to optimize integration of these implants into the body.  
Thus, researchers have been working to enhance magnesium-based biomaterials with a 
variety of surface modifications in order to control their degradation rate and their 
biocompatibility. 
The main objective of this thesis was to develop surface modification strategies that 
result in controlled degradation of magnesium alloys in physiological environments while 
simultaneously enhancing the biocompatibility of the surface. The thesis contains three 
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individual studies that are summarized below. In the first project a method for quantifying the 
cytotoxicity and cell adhesion/proliferation of magnesium alloys by both direct and indirect 
method was evaluated. In the second project a multi-layered coating was developed; the surface 
chemistry of the coating, its influence on the biodegradation rate of the magnesium alloy and its 
cytotoxicity were studied. In the third project, the preliminary results of a study on the 
immobilization of a cell adhesive ligand to the surface of a superhydrophobic magnesium alloy 
and its influence on the biocompatibility of the samples is reported.  
Project 1:  Evaluation of the Biocompatibility of Magnesium Alloys by Direct and Indirect 
Methods 
In order to evaluate newly designed biomaterials, it is essential to develop accurate 
testing methods to determine the biocompatibility of magnesium and its alloys to ensure that they 
are safe for use in medical applications. According to the International Organization for 
Standardization (ISO), various methods and conditions are suggested to evaluate the in vitro 
biocompatibility of recently developed biomaterials including direct and indirect techniques that 
quantify the cytotoxicity and cell adhesion/proliferation in the presence of biomaterials. The 
direct method involves direct contact between the material and the cultured cells while the 
indirect method involves exposing healthy, growing cells to an extract created by immersing the 
material in cell culture medium for a specified period of time. The current ISO standards were 
developed for the testing of medical devices in general and not specifically for degradable 
magnesium materials or other oxidizable metallic materials. Therefore, the most commonly used 
assays employed are not useful for these types of materials due to a false positive result that 
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occurs when the assay dye is reduced by the electrons released during metal oxidation. The MTT 
assay is an example of an assay that depends on chemical reduction of the dye molecules for cell 
quantification leading to a false positive in the presence of a corroding metal. 
𝑀𝑒𝑡𝑎𝑙 → 𝑀𝑒𝑡𝑎𝑙𝑛+ + 𝑛𝑒− 
This has led to a preponderance of studies that test the cytotoxicity of the soluble 
degradation products of the biodegradable metals via an indirect method and few articles that 
quantify cell adhesion/proliferation directly in the presence of the biodegradable metal. In 
addition, this false positive has caused some materials scientists to avoid these in vitro tests 
altogether and proceed directly to in vivo testing. While in vivo testing gives a more complete 
evaluation of the biocompatibility of an implant material, in vitro testing is still an essential 
screening tool to choose the most likely candidate materials and thus minimize the number of 
animals that must be sacrificed.  
Therefore, it is very important to establish an alternative in vitro assay that can be used in 
a direct method to more accurately mimic the expected in vivo conditions. In this study, a non-
common assay was evaluated for its ability to determine the biocompatibility of magnesium 
alloys by both direct and indirect methods. The CyQUANT assay uses a dye molecule that 
strongly fluoresces when bound to cellular nucleic acids and, therefore, does not undergo a 
colorimetric change in response to cellular metabolic reduction. This assay is not subject to the 
same false positive result that has been observed with other assays. The key objectives of this 
study were: 
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• To show that a cyanine dye-based assay can be used to evaluate cell 
adhesion/proliferation in direct contact with magnesium metals with no false 
positive result. 
• To evaluate the CyQUANT assay as a tool to quantify the biocompatibility of 
magnesium alloys by both direct and indirect methods.  
Project 2:  Development of a Biocompatible Calcium Phosphate Coating with Improved 
Degradation Resistance for Biodegradable Magnesium Implant Materials 
As discussed above, the rapid degradation of magnesium has prevented its widespread 
use in medical applications. Therefore, the key objectives of this project were: 
• To develop a multi-layered surface modification strategy for magnesium alloys 
that controls both the degradation rate and the biocompatibility of these materials.  
The multilayers consist of an initial sol-gel silica layer, followed by a spin coated 
of mesoporous silica layer and finally a calcium phosphate layer 
• To optimize the coating conditions for each layer by characterizing the surface 
chemistry and topography of each layer at various deposition condition.   
• To produce multi-layer coating that are uniform, stable and biocompatible 
• To characterize the biodegradation rate and of the optimized multi-layered 
coating.    
Project 3:  Preliminary Results on Immobilization of a Fibronectin Mimetic to the Surface 
of Superhydrophobic Magnesium and its Influence on Cell Adhesion  
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Superhydrophobic surfaces are of interest for corrosion control due to their extreme water 
repellence. However, while superhydrophobic surfaces have been shown to decrease the 
corrosion rate of magnesium alloys, superhydrophobic surfaces have also been shown to inhibit 
cell adhesion which is an important factor for cell survival and proliferation at implant surfaces. 
The arginylglycylaspartic acid (RGD) amino acid sequence is an amino acid sequence found in 
fibronectin, an important extracellular matrix (ECM) that mediates cell adhesion to surfaces. 
MAPTRix-F-RGD is a mussel adhesive protein that contains the RGD peptide. Mussel adhesive 
protein is a “super glue” that readily adheres to virtually any substrate, even very low surface 
energy superhydrophobic materials. The key objectives of this project were:  
• To reproduce a superhydrophobic surface on magnesium alloy AZ31. 
• To develop a method for the immobilization of the MAPTrix-F-RGD protein to 
the superhydrophobic Mg AZ31.  
• To study the influence of this surface modification on Saos-2 osteoblast adhesion 
to the modified surfaces in comparison to unmodified superhydrophobic surfaces  
In this study, the best conditions for deposition of MAPTrix-F-RGD protein on 
superhydrophobic magnesium surfaces were determined and the surface chemistry was 
characterized. The number of cells adhered to the modified and unmodified superhydrophobic 
surfaces were quantified to determine if the presence of cell adhesive ligands has any impact on 
the cell adhesive properties of the surface. 
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Abstract 
Magnesium and its alloys are promising candidates to be employed as a new generation 
of biodegradable metals in orthopaedic applications due to their excellent biocompatibility, 
biodegradability, and mechanical properties that are similar to natural bone. However, direct in 
vitro assessment of these materials in the presence of cells is complicated by degradation 
products from the alloy that lead to a false positive for the most commonly used cell adhesion 
and cell proliferation assays. In this paper, the cyanine dye was used to quantitatively evaluate 
the in vitro biocompatibility of a Mg AZ31 alloy by both direct and indirect methods. The 
cytotoxicity of the corrosion products was evaluated via an indirect method; a 25% decrease in 
cell viability compared to control samples was observed. Moreover, direct assessment of cell 
adhesion and proliferation showed a statistically significant increase in cell number at the surface 
after 72 hours.  In addition, the degradation rate and surface characteristics of the Mg AZ31 alloy 
were evaluated in direct and indirect tests. The degradation rate was unaffected by the presence 
of cells while evidence of an increase in calcium phosphate deposition on the magnesium alloy 
surface in the presence of cells was observed. This study demonstrates that the cyanine dye 
provides a more accurate assessment of the overall in vitro biocompatibility of biodegradable 
metals than the more commonly used assays reported in the literature to date. 
Keywords: Magnesium alloys, biocompatibility, direct method, indirect method, cyanine dye, 
CyQUANT assay, cell adhesion, cell proliferation, cytotoxicity 
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3.1 Introduction 
Biomaterials are used in the replacement and treatment of diseased or injured tissue in 
different parts of the body; some examples include cardiovascular, dental and orthopaedic 
implants [1]. The development of biomaterials for orthopaedic applications has been a significant 
challenge to biomaterials scientists. The optimum biomaterials for orthopaedic implants should 
be non-toxic and biocompatible with the human body [2]. Furthermore, they should have 
excellent mechanical properties for the intended application and for applications such as fracture 
fixation, these biomaterials should be biodegradable to prevent the need for additional surgery to 
remove the implant after healing has occurred [3]. 
Magnesium and its alloys are a promising alternative for biodegradable orthopaedic 
implants that decrease stress shielding and enhance new bone growth due to their 
biodegradability, biocompatibility, and mechanical properties that are similar to natural bone. 
The biodegradability of magnesium provides a good advantage for short term implants that can 
dissolve after healing without the need of a second surgery to remove the implant.  
Although magnesium itself is biocompatible [4,5], the degradation process in 
physiological environments that are rich in chloride ions can cause several complications for the 
surrounding tissues due to the rapid pH change and hydrogen gas production. The 
electrochemical reaction that occurs is shown in Reaction Scheme 3.1. Magnesium metal is 
oxidized to produce magnesium ions while water is reduced to form hydroxide ions and 
hydrogen gas [6].   
47 
 
 
 
Reaction Scheme 3.1: General Degradation Mechanism of Magnesium. 
Anodic reaction:          Mg(s) → Mg2+ (aq) + 2e-  
Cathodic reaction:       2H2O (l) + 2e
- → 2OH- (aq) + H2 (g) 
Product formation:      Mg2+ (aq) + 2OH
- 
(aq) → Mg(OH)2 (s)  
General reaction:         Mg(s) + 2H2O (l) → Mg(OH)2 (s) + H2 (g) 
Mg alloys contain small amounts of additional elements such as aluminum, zinc, 
manganese and rare earth elements that enhance the mechanical strength and corrosion resistance 
of these materials. In addition, alloying elements that play an important role in biological activity 
such as calcium and strontium may also be present. The release of magnesium ions, hydroxide 
ions, hydrogen gas, and other alloying elements during the biodegradation process affects the 
overall biocompatibility of magnesium alloys. Therefore, it is essential to develop accurate 
testing methods to assess their biocompatibility and to ensure that they are safe for use in 
medical applications [7]. 
According to the International Organization for Standardization (ISO), various methods 
and conditions are suggested to evaluate the biocompatibility of recently developed biomaterials. 
These methods include both direct and indirect techniques [8,9]. 
For magnesium and its alloys, an indirect method is the most common way to evaluate 
their biocompatibility. This indirect method involves studying the effects of cell culture media 
that have been pre-conditioned through exposure to the biodegradable material on already 
growing cells [7]. This indirect test evaluates the effect of the soluble degradation products on 
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the cell viability. Many studies use this indirect method of evaluation for magnesium because a 
false positive is commonly observed when the assays are conducted in the presence of the 
magnesium material [10]. For example, the MTT assay, which is commonly used to directly 
quantify cell proliferation at the surface of biomaterials, involves the conversion of the yellow 
tetrazolium salt into a purple formazan dye by chemical reduction. Using this assay in the 
presence of biodegradable metals leads to a false positive result as the MTT dye is reduced by 
the electrons released during metal oxidation (Reaction Scheme 3.1) [10].    
Although evaluating the cytotoxicity of the degradation products for biodegradable 
materials is one indicator of their biocompatibility, cell adhesion and cell proliferation at the 
surface of these materials are also important factors to consider. Therefore, in order to fully 
evaluate the in vitro biocompatibility of biodegradable magnesium, it is also important to 
develop direct tests for the quantification of cell adhesion and proliferation on the surface of the 
metal.    
The determination of cellular nucleic acid content provides a reasonable measure of cell 
numbers. These types of assays do not rely on a colorimetric change due to chemical reduction 
but rather take advantage of the interaction of a fluorescent dye with cellular DNA and thus 
should not exhibit the false positive result discussed above. This makes them suitable for 
quantifying cell adhesion and proliferation directly in the presence of a biodegradable metal. The 
cyanine dyes bind to double helical DNA by either intercalation between the base pairs of DNA 
or insertion into the minor groove of the double helical DNA resulting in high fluorescence 
enhancement [11].  
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The general structure of cyanine dyes consists of two nitrogen centers that are typically 
part of two heterocyclic aromatic groups, linked by a conjugated polymethine chain that has an 
odd number of carbon atoms. Some of the most common heterocyclic aromatic groups are 
quinoline, indole, benzoxazole, and benzothiazole. The general structure of cyanine dyes is 
shown in Figure 3.1.  
 
Figure 3.1: The General Structure of Cyanine Dye 
Cyanine dyes can be classified as either symmetrical or unsymmetrical dyes. The 
symmetrical dyes are formed of identical heterocyclic aromatic groups linked at the same 
position whereas asymmetrical dyes contain either two different heterocycles or identical 
heterocyclic aromatic groups linked at different positions. The structure of the dyes plays a very 
important role in how they interact with the DNA [12,13,14]. Cyanine dyes have properties of 
both intercalators and minor groove binders and thus, either one or both of these binding modes 
has been observed. The planar heterocycles of the dye readily intercalate between the base pairs 
of DNA whereas the semiflexible polymethine chain allows the molecule to twist and follow the 
minor groove [12]. Upon binding, cyanine dyes exhibit significant fluorescence enhancement as 
a result of restricted internal rotation of the dye molecules. 
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The CyQUANT assay that was used in this study is an example of an assay that is based 
on the binding of a cyanine dye to nucleic acids. It is a quick and reliable method to evaluate the 
biocompatibility of a material and can detect as few as 10-50 cells and as high as 25,000-50,000 
cells depending on cell type. The linear range of this assay can be further extended to cell 
numbers as high 100,000-250,000 cells by increasing the cyanine dye concentration [11]. 
In contrast to indirect techniques that evaluate cell viability in the presence of pre-
conditioned cell media, direct methods allow for evaluation of the biocompatibility of 
magnesium alloys in the presence of the biocorrosion process. The effect of Mg ions that 
dissolve in cell culture media, the rapid pH change, the hydrogen gas produced and the 
deposition of corrosion products during biocorrosion all have an influence on biocompatibility. 
However, direct evaluation methods have been avoided by many researchers for biodegradable 
magnesium materials due to false positive results from the most commonly used assays [7,10].  
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Figure 3.2: Survey of Methods Used to Evaluate the Biocompatibility of Magnesium 
Materials in Publications from 2014-2018. A Complete List of the References Used to Prepare 
this Figure can be Found in Appendix 1. 
Figure 3.2. shows the results of our literature survey of the methods used to evaluate the 
biocompatibility of magnesium materials from 2014 to 2018. Of the 150 journal articles 
surveyed, 70% reported using an indirect method to evaluate biocompatibility. As shown in 
Figure 3.2, the most common method used to evaluate the biocompatibility of magnesium was 
the indirect method with the MTT assay. Other assays used for the indirect method include the 
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MTS, WST-1, WST-8 and Alamar Blue assays. All of these assays undergo a colorimetric 
change when a dye is chemically reduced in response to cellular metabolism and are therefore 
unsuitable for quantifying cell adhesion/proliferation in the presence of magnesium due to the 
expected false positive result. Despite the known false positive, the MTT assay was also 
employed in a direct biocompatibility test in 17% of the articles surveyed. Moreover, about 8% 
of the articles evaluated the biocompatibility of magnesium by a direct method using other 
assays that also undergo a colorimetric change via chemical reduction. Overall only 4% of the 
articles reviewed evaluated biocompatibility by a direct method that did not employ an assay that 
would be expected to give false positive results. This literature survey highlights the need for a 
reliable method to quantify cell adhesion/proliferation for cells in direct contact with magnesium 
biomaterials. The CyQUANT assay, used in only 6 of the 150 articles surveyed, should not result 
in a false positive and can be used to quantify cell numbers by both direct and indirect methods.  
The objective of this research was to demonstrate the applicability of the cyanine dye for 
the in vitro evaluation of the biocompatibility of biodegradable magnesium materials by both 
direct and indirect methods.    
3.2 Experimental Details  
3.2.1 Materials 
Mg AZ31 foil (0.81mm thickness) was purchased from Alfa Aesar (US). Acetone 
(reagent grade) was purchased from Caledon Laboratory Chemicals (Canada). Bovine Calf 
Serum (BCS) and Trypan Blue were purchased from Fisher Scientific (Canada). McCoy’s 5a 
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culture medium and Trypsin/EDTA (1X) were purchased from Corning (Canada). Phosphate 
Buffered Saline (PBS) (1X) and Penicillin-Streptomycin Solution were purchased from HyClone 
(Canada). The CyQUANT Cell Proliferation Assay kit was purchased from Life technologies 
(Canada). Ethyl alcohol (95%) and methanol were purchased from Commercial Alcohols 
(Canada). All chemicals were used as received without further purification. The Saos-2 cell line 
was purchased from American Type Culture Collection (ATCC, Bethesda, MD USA).  
3.2.2 Preparation of Mg AZ31 Alloys 
Mg AZ31 alloy sheets were cut into circular discs with a diameter of 1.27 cm. These 
discs were polished on both sides with a 320 grit P400 grinding paper and oil-based lubricant 
(Buehler). In order to remove any excess polishing oil from the surface of the alloys, the samples 
were sonicated in acetone for 20 minutes and then rinsed in deionized water for 30 seconds. 
Finally, the samples were air dried. 
3.2.3 Cell Culture   
Human osteosarcoma Saos-2 cells were cultured in McCoy’s 5a cell culture medium 
containing 15% Bovine Calf Serum and 1% penicillin/streptomycin at 37oC in a 5% CO2 
humidified atmosphere. The cell culture medium was changed every two days. Once the cells 
grew to 70-80% confluence, they were washed with warm (37oC), sterile PBS and detached from 
the flask with Trypsin/EDTA and then centrifuged at 2500 rpm for 5 minutes. The supernatant 
was discarded, and the cells were resuspended in fresh McCoy’s medium. The number of cells in 
the suspension was determined by the trypan blue dye using a Neubauer hemocytometer.  
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3.2.4 Direct Method Procedure 
The Mg Alloy samples were sterilized in 70% ethanol for 20 minutes and then rinsed 
with warm PBS. The samples were placed in the wells of a 24-well plate, 25,000 cells in 2 mL of 
McCoy’s medium were added to each well and the plate was incubated for 24, 48, and 72 hrs at 
37oC in a 5% CO2 atmosphere. After the desired incubation period, a 25 µL aliquot was taken 
from the cell culture medium and diluted to 25 mL with 2% HNO3 in a volumetric flask to 
determine the amount of Mg ions dissolved in the cell culture medium. Subsequently, the Mg 
alloys were rinsed with warm PBS in order to remove non-adherent cells, then the plate was 
frozen at -20ºC at least 24 h for the cells to lyse. For cell number determination, the plate was 
allowed to thaw and processed for the CyQUANT assay, according to the supplier’s instructions. 
Briefly, 200 µl of CyQUANT solution was added to each sample and incubated for 5 minutes. At 
the end of the incubation period, 100 µL of the CyQUANT solution was pipetted from each well 
to a black fluorescent 96-well plate (Costar) and the fluorescence intensity of each solution was 
measured with a Fluostar Optima spectrofluorometer. The cell number was then determined 
using a calibration curve of cell number vs. fluorescence intensity. In addition, cells grown on 
the bare well surface (in the absence of magnesium discs) was used as a positive control group 
for cell adhesion while the blank consisted in Mg AZ31 disks incubated in culture medium in 
absence of cells. The experiment was repeated two times on different days to ensure the 
reliability of the results. Each individual experiment was an analysis of 3 samples at each 
incubation time.  
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The percentage of Saos-2 cells adhered directly to the Mg AZ31 surface as a function of 
time was determined using this direct method. The quantitative data were reported as a 
percentage of the number of cells attached to the surface in comparison to the initial number of 
cells seeded (25,000 cells). The cell adhesion percentage was calculated by the following 
equation: 
𝐶𝑒𝑙𝑙 𝐴𝑑ℎ𝑒𝑠𝑖𝑜𝑛% =  (
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑑ℎ𝑒𝑟𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
25,000
) ∗ 100 
The lack of false positive for the CyQUANT assay was tested through a control 
experiment that measured the fluorescence of the dye in the presence of magnesium but in the 
absence of cells. The fluorescence intensity measured in the absence of cells was very low, 
usually in the range (125-375).  
3.2.5 Indirect Method Procedure 
 Preparation of Magnesium Conditioned Media (Magnesium 
Extract) 
Prior to the indirect experiment, all magnesium alloy samples were sterilized in 70% 
ethanol for 20 minutes followed by washing with warm PBS. The Mg alloy samples were placed 
in individual wells of a 24-well plate that contained only cell culture medium (2 mL of McCoy’s 
medium) and then incubated for 24, 48, and 72 hrs at 37oC in a 5% CO2. After the incubation 
periods, a 25 µL aliquot of the cell culture medium was taken from each well and diluted to 25 
mL using 2% HNO3 in a volumetric flask. The Mg alloys were then rinsed in water and set aside 
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for further analysis (Section 3.2.6). Cell culture medium was used as a control to compare the 
concentrations of magnesium ions in the presence vs absence of magnesium alloy samples.   
 Evaluation of Cell Viability 
To determine the effect of magnesium on the viability of cells, 15,000 cells were seeded 
in a 96-well plate in triplicate. Cells were incubated at 37oC in a 5% CO2 atmosphere for 24 
hours to allow cell attachment to the plate surface. After 24 hours of incubation, the cell culture 
medium was removed and 200 µL of the magnesium extract (Mg-conditioned medium) was 
added to a 96-well plate with the already growing cells. The plate was then incubated for 24 hrs 
at 37oC in a 5% CO2 atmosphere. After 24 hrs, the magnesium conditioned medium was 
removed, and the cells in the 96-well plates were rinsed with warm PBS in order to remove non-
adherent cells, then the plate was frozen at -20ºC overnight for the cells to lyse. The cell numbers 
were then determined using the CyQUANT assay as described above. Cells grown in the absence 
of magnesium extract were used as a control group to determine the cell viability. The entire 
experiment was repeated two times on different days to ensure the reliability of the results. Each 
individual experiment tested 3 samples of each type set (cells only, 24 hours extract medium, 48 
hours extract medium, 72 hours extract medium).  
The percentage of viable Saos-2 cells in the presence of magnesium alloy conditioned 
extract that had been pre-conditioned for 24, 48 and 72 hours was determined using this indirect 
method. The quantitative data are reported as a percentage of the number of cells in the presence 
of Mg conditioned cell culture media in comparison to the number of cells in the absence of Mg 
57 
 
 
 
conditioned cell culture media (control). The cell viability percentage was calculated by the 
following equation: 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦% = (
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑡𝑜 𝑀𝑔 𝑒𝑥𝑡𝑟𝑎𝑐𝑡
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑠𝑎𝑚𝑝𝑙𝑒
) ∗ 100 
3.2.6 Instrumental Analysis 
 Attenuated Total Reflectance-Fourier Transform Infrared 
Microscopy (ATR-FTIR) 
Attenuated total reflection Fourier transform infrared microscopy (ATR- FTIR) was used 
to analyze the surface of the Mg AZ31 alloy discs after exposure to the cells and the cell culture 
medium in the direct method and to the cell culture medium alone in the indirect method. A 
Bruker Optics Hyperion infrared microscope with an attenuated total reflectance objective and a 
germanium crystal was employed. The main goal of this technique was to determine the 
chemical functional groups present on the surface of the magnesium alloys after the direct and 
indirect method. The spectra were taken in three spots for each sample and were corrected with 
the atmospheric compensation function of the OPUS software to remove water vapour and CO2 
from the spectra. 
 Flame Atomic Absorption Spectroscopy (FAAS)  
A Perkin Elmer AA analyst 400, flame atomic absorption spectrometer was used to 
determine the degradation rate of the magnesium alloys after exposure to the cells and the 
growth medium in the direct method and to the growth medium alone in the indirect method. 
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This technique was used to measure the concentration of magnesium ions that have been released 
into the cell culture medium in the presence and absence of the cells. The amount of magnesium 
released from the samples was quantified using a calibration curve for standards of known 
concentrations of magnesium (0.05, 0.1, 0.2, 0.5 mg/L). Unmodified cell culture medium was 
used as the control. The results are reported as the average ± standard deviation for three 
different samples of each type.    
 Scanning Electron Microscopy-Energy Dispersive X-ray 
Spectroscopy (SEM-EDS) 
Scanning electron microscopy was used to evaluate the surface topography of the 
samples after the direct and indirect cell tests. SEM images were obtained using a digital 
scanning electron microscope (JEOL 6400) operated at 20 kV with a beam current of 1 nA. 
Energy Dispersive X-ray Spectroscopy (EDS) was used to determine the elemental composition 
of the degradation products on the surface. Samples to be analyzed were coated with a thin film 
of carbon to render the sample conductive.  
3.2.7 Statistical Analysis 
Quantitative results are reported as an average±standard deviation of multiple sample 
trials. The number of samples used in each data is indicated in the ﬁgure captions. Statistical 
signiﬁcance of the observed differences in the cell adhesion% and cell viability% data was 
determined with a paired student t-test. A value of p <0.05 was assumed to indicate statistically 
signiﬁcant differences. 
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3.3 Results and Discussion 
3.3.1 Evaluation of the Biocompatibility of Mg AZ31 Alloy by CyQUANT 
Assay 
The main objective of this study was to compare the usefulness of the CyQUANT assay 
in a direct and indirect method for evaluating the biocompatibility of magnesium alloy AZ31 in 
vitro. This assay is a quick and reliable technique that can be readily adapted for use in direct and 
indirect methods. The CyQUANT assay does not depend on a reaction with cellular metabolic 
products but instead is based on the interaction of a dye with the cellular nucleic acids.  
 Direct Method 
 
Schematic Diagram 3.1: The Schematic Diagram of the Direct Method 
In the direct method, cells were grown directly on the surface of the Mg AZ31 discs for a 
selected time interval (24 hrs, 48 hrs, and 72 hrs) as shown in Schematic Diagram 3.1. After the 
incubation time, the magnesium disc was removed, and the non-adherent cells were rinsed from 
the surface in order to quantify only the cells adhered to the Mg alloy surfaces.  
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Figure 3.3: The Percentage of Saos-2 Cells Adhered to the Mg AZ31 Surface as a Function 
of Time Evaluated by the Direct Method. Results are Reported as a Percentage of the Number 
of Cells Attached to the Surface in Comparison to Initial Number of Cells Seeded. “Cells only” 
is the Data for the Control Group Grown in the Cell Culture Plate while “Mg+Cells” is the Data 
for Cells Attached to the Mg AZ31 Surface.  Data are the Average of 6 Samples (3 Replicates of 
2 Independent Experiments). * Indicates p<0.05 between 24 hrs and 72 hrs, ¶ Indicates p<0.05 
between 48 hrs and 72 hrs, and † Indicates p<0.05 between 24 hrs and 48 hrs. 
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Figure 3.3 shows the percentage of cells adhered to the Mg AZ31 samples after 
incubation periods of 24, 48, and 72 hours. The results show that the percentage of cells on the 
positive control (cells only) increased as a function of time indicating cell proliferation in the 
well. Also, the percentage of cells on the Mg AZ31 alloy surface increased significantly over 
time but with overall low cell numbers in comparison to the control samples. The low percentage 
of cells on the Mg AZ31 surface may be attributed to the corrosion of the magnesium alloy 
surface in aqueous environments resulting in the production of hydrogen gas bubbles and an 
increase in pH of growth medium. However, the results show a statistically significant difference 
in cell number on the magnesium alloy sample after 72 hours. In fact, after 72 hours the cell 
number increases by 105% on the magnesium alloy surface in comparison to an increase of only 
70% for the control samples. This indicates that although the initial adhesion of cells to the 
magnesium samples is low, the adhered cells were able to proliferate significantly over 72 hours. 
Thus, using the CyQUANT assay, we were able to show that Mg AZ31 has the ability to 
promote cell adhesion and cell proliferation over time.  
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 Indirect Method 
 
Schematic Diagram 3.2: Schematic Diagram of the Indirect Method 
 In the indirect method, cells were growing on the surface of a plastic 96-well plate are 
exposed to cell culture medium that had been pre-conditioned with magnesium alloy for 24, 48 
and 72 hours as shown in Schematic Diagram 3.2. After incubation of the cells in the presence of 
the conditioned medium for 24 hours, the magnesium conditioned cell culture medium was 
removed, the wells rinsed with PBS to remove non-adherent cells and the number of viable cells 
determined with the CyQUANT assay. Cells grown in well (in the absence of magnesium 
extract) were applied as a control group in this study to determine the cell viability for each 
sample group.  
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Figure 3.4: The Percentage of Saos-2 Cell Viability Using the Indirect Method in the 
Presence of Mg Alloy Conditioned Extracts that had been Pre-conditioned for 24, 48 and 
72 hours. The Quantitative Data are Reported as a Percentage of the Number of Viable Cells in 
the Presence of Mg Alloy Conditioned Extract Compared to Number of Viable Cells in 
Unmodified Cell Culture Medium (Control). Data are the Average of 6 Samples (3 Replicates of 
2 Independent Experiments). 
 Due to the biodegradation of the Mg alloy samples, magnesium ions, hydroxide ions and 
ions of alloying elements are released into the cell culture medium. The rise in pH and the 
presence of potentially toxic ions may negatively affect the cell viability. Figure 3.4 shows the 
viability of Saos-2 cells in the presence of the Mg-conditioned medium after 24, 48 and 72 hours. 
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It was observed that the cells exposed to the conditioned Mg AZ31 extract had similar cell 
viability regardless of conditioning time. According to ISO, if the cell viability is reduced by 
more than 30%, the material is considered to be cytotoxic [9]. However, these results show that 
cell growth in the Mg alloy conditioned cell culture medium for 24, 48 and 72 hours all 
decreased the cell viability by only 25% on average. No statistically significant difference in the 
percentage of cell viability was noted for the different conditioned media (p > 0.05). 
Determination of the Biodegradation Rate of Mg alloy AZ31 in the Cell 
Culture Medium in the Presence and Absence of Cells 
In order to evaluate the influence of cells on the biodegradation rate of Mg AZ31, the 
amount of magnesium dissolved in cell culture medium as a function of time was determined by 
flame atomic absorption spectroscopy (FAAS). Magnesium ions are released into cell culture 
medium as the magnesium metal is oxidized to Mg2+ in the aqueous solution.    
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Figure 3.5: The Amount of Mg Dissolved as a Function of Time in the Cell Culture 
Medium in the Presence and Absence of Cells.  Each Data Point Represents an Average of 3 
Samples; the Error Bars are the Sample to Sample Standard Deviations. 
 Figure 3.5 shows a graph of the amount of magnesium dissolved into the cell culture 
medium as a function of time over a 72-hour period in the presence (direct method) and absence 
(indirect method) of cells. The amount of Mg ions released into the cell culture medium was the 
same in the presence (direct) and absence (indirect) of cells. Therefore, the cells did not inhibit or 
enhance the corrosion of Mg alloys AZ31 up to 72 hours. However, Agha et al. reported that the 
influence of cells on the degradation of pure Mg and Mg alloys was more apparent after 14 days 
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of immersion than 4 days of immersion in cell culture medium in their study on the degradation 
of magnesium in the presence and absence of osteoblast cells. A decrease in the degradation rate 
of pure Mg and Mg-10Gd was observed in the presence of cells compared with the samples in 
the absence of cells. These results were attributed to the formation of more hydroxyapatite in the 
presence of osteoblast cells which increased over time [15]. This will be discussed in more detail 
in later sections. 
In addition, although the concentration of magnesium in the cell culture medium at 72 
hours was close to two times the amount measured at 24 hours there was no increase in the 
observed cell cytotoxicity measured by the indirect method. For the direct method, cell 
proliferation was observed despite the increase in magnesium ions in the cell culture medium. 
These results are consistent with the literature as it has been previously reported that increased 
magnesium ions levels stimulate new bone growth [16,17]. Numerous of studies have stated the 
enhancement of bone growth around the corroded magnesium implant in vivo [18,19,20]. As has 
been shown in the literature, the presence of magnesium on orthopaedic implants may enhance 
osteoblastic cell adhesion in vitro. Pietak et al. has shown that magnesium-based substrates can 
promote bone cell attachment on the implant surface in an in vitro experiment [21]. Furthermore, 
Li et al. have shown that Mg-1Ca alloy did not induce toxicity to cells and had high activity of 
osteoblast and osteocytes around the alloy in an in vivo experiment [20]. 
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3.3.2 Characterization of the Surface of Mg AZ31 Alloy after Direct and 
Indirect Methods 
After each incubation time, the samples were analyzed by SEM-EDS in order to evaluate 
the morphology and surface elemental composition of the magnesium alloy after exposure to the 
mixture of the cells and the cell culture medium in the direct method and to the unmodified cell 
culture medium in the indirect method. The samples were also analyzed by ATR-FTIR in order 
to identify the precipitation products on the surface. One of the expected degradation products on 
the surface of magnesium alloys after exposure to the cell culture medium solution is calcium 
phosphate [22] due to their low solubility in aqueous solution, particularly at elevated pH.   
As the magnesium alloy degrades, the pH rises, resulting in precipitation of calcium 
phosphate species such as hydroxyapatite as shown in reaction scheme 3.2. 
Reaction Scheme 3.2: Precipitation Reactions 
10Ca2+ (aq) + 6PO4
3- 
(aq) +2OH
- 
(aq) → Ca10 (PO4)6 (OH)2 (s)         
Furthermore, other precipitation products are possible on magnesium alloy surfaces after 
exposure to cell culture media such as other calcium phosphates, magnesium phosphate, 
magnesium hydroxide and magnesium carbonate [23].    
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Figure 3.6: SEM Images of the Magnesium Alloy AZ31 Surface after the Direct and 
Indirect Methods. (a, b, c) Samples after 24, 48,72 hours by the Direct Method, (d, e, f) Sample 
after 24, 48,72 hours by the Indirect Method. Scale Bar = 100 µm. 
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Figure 3.6. shows representative SEM images of the surface of the Mg AZ31 alloy 
samples after incubation in the cell culture medium in the presence (a, b, c) or absence (d, e, f) of 
osteoblast cells. The SEM image of a polished bare magnesium surface before testing showed 
that the polished Mg AZ31 surface was flat with lines due to polishing (image is not shown). The 
SEM images of all of the samples after either the direct or indirect test are completely covered 
with a layer of corrosion product. The cracking of the layer is due to dehydration of the corrosion 
product as it dries. This layer was readily observed on the magnesium substrate after 24 hrs of 
exposure to the cell culture medium both in the presence and absence of cells. Thus, the presence 
of cells in the culture medium does not change the surface morphology of the layer deposited on 
the magnesium alloy surface. The presence of both calcium and phosphorus on these surfaces 
was confirmed by EDS indicating that the deposited layer is calcium phosphate as expected. This 
will be discussed in more detail in subsequent sections. 
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Figure 3.7: The Ratio of Weight Percentage for Ca/Mg Deposited on the Surface of Mg 
AZ31 after the Direct and Indirect Methods. Each Data Point Represents an Average of 3 
Samples and 9 Spots on each Samples; the Error Bars are the Sample to Sample and Spot to Spot 
Standard Deviations. 
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Figure 3.8: The Ratio of Weight Percentage for P/Mg Deposited on the Surface of Mg AZ31 
after the Direct and Indirect Methods. Each Data Point Represents an Average of 3 Samples 
and 9 Spots on each Samples; the Error Bars are the Sample to Sample and Spot to Spot Standard 
Deviations. 
All of the samples were analyzed by EDS in order to determine the elemental 
composition of the degradation products that had been formed on the surface of the magnesium 
alloy after both the direct and indirect cell tests.  
Figure 3.7 shows the Ca/Mg ratio while Figure 3.8 shows the P/Mg ratio as a function of 
time for samples exposed to cell culture media alone (indirect test) and cell culture medium and 
cells (direct test). The EDS results indicate that the Ca/Mg and P/Mg ratio on the surface of Mg 
alloys for both the direct and indirect methods was slightly increased with increased incubation 
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time from 24 to 48 hrs. After 72 hrs, the ratio of Ca/Mg and P/Mg that was deposited on the 
surface of the Mg alloys after the direct method increased indicating an increase in the thickness 
of the calcium phosphate layers in the presence of cells with increasing incubation time. In 
comparison, the ratios of Ca/Mg and P/Mg on the surface of Mg AZ31 in the absence of cells 
(indirect method) after 72 hrs were not increased. Thus, although the morphologies are similar as 
seen in Figure 3.6, the thickness of the calcium phosphate layer appears to be influenced by the 
presence of cells.  
These results can be attributed to the ability of the Saos-2 osteoblast cells to produce 
calcium phosphate as has been reported in numerous of studies. Human osteoblast cells play an 
important role in the formation of bone by inducing and regulating the mineralization of the 
extracellular matrix. Saos-2 cells can also more closely mimic the in vivo environment than other 
commonly used osteoblast cell lines [15,24,25,26]. Agha et al. found more hydroxyapatite on a 
magnesium surface in the presence in comparison to the absence of cells. Specifically, their 
study reported that finding more Ca and P contents near the cells than underneath the cells [15].   
In addition, Strzelecka-Kiliszek, et al. compared the formation of minerals on two 
selected osteoblastic cell models: osteosarcoma Saos-2 cells and human foetal hFOB 1.19 cells 
and it was observed that Saos-2 cells had higher amount and composition of minerals compared 
to  hFOB 1.19 cells and that Saos-2 cells mineralized better than hFOB 1.19 cells since the ratio 
of calcium to phosphate was closer to hydroxyapatite. Therefore, the choice of osteoblast cell 
line is an important consideration for the direct method since each cell line shows different 
characteristics in terms the extracellular matrix and mineralization production [27]. 
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Figure 3.9: IR Spectra of MgAZ31 after the Direct and Indirect Methods (72 hour 
Incubation Time). (a) Sample before Test, (b) Sample after Direct Method and (c) Sample after 
Indirect Test. 
The magnesium alloy was also analyzed by ATR-FTIR in order to further identify the 
precipitation products on the surface. Figure 3.9 shows IR spectra of MgAZ31 surface before and 
after exposure to the cells. The IR spectrum for a polished and cleaned magnesium alloy has a 
(a) 
(b) 
(c) 
PO43- 
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small peak at 3700 cm-1 (O-H stretch) which indicates the presence of Mg-OH bonds at the 
surface. A broad peak at 3000 cm-1 (O-H stretch) was also observed coupled with a peak at 1640 
cm-1 (O-H bend) due to the surface adsorbed water. Carbonate (CO3
2-) is also observed at (1450 
cm-1) due to the reaction of the magnesium substrate with carbon dioxide in the atmosphere. 
Furthermore, peaks at 2850-2930 cm-1 (CH2/CH3 stretch) were observed indicating a small 
amount of organic contamination on the surface. As shown in Figure 3.9, all the sample surfaces 
exhibited a strong phosphate peak at 1050 cm-1 confirming that the phosphorus peak observed in 
the EDS spectra which is due to the presence of phosphate, PO4
3-, at the magnesium alloy 
surface. Furthermore, the carbonate peak at (1450 cm-1) is still observed after the direct and 
indirect test; this is attributed to the presence of carbonate within the deposited surface layer. The 
deposition of this calcium phosphate layer on the surface of the Mg alloy may lead to enhanced 
bone-implant contact and induce early bone formation [19,20]. Therefore, the presence of cells in 
direct contact with this layer is a very important factor for the evaluation of the biocompatibility 
of magnesium biomaterials.  
3.3.3 Comparison of the Direct and Indirect Methods using the CyQUANT 
Assay 
Each material developed for medical applications must be biocompatible, which means it 
does not have toxic or carcinogenic effects and also can be tolerated by the human body without 
inducing inflammation or injury to the surrounding tissue [28]. In vitro studies of the 
biocompatibility of a material are an important preliminary step to investigate the potential safety 
of using these materials for in vivo studies [29]. The in vitro study of the biocompatibility of 
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biodegradable magnesium alloys is mainly carried out using cell culture [29]. There are two 
primary methods that have been adapted from the international standards organization for 
evaluating the biocompatibility of biomedical devices [8,9]. The first method involves direct 
contact between the material and the cultured cells (direct method). The second method is to 
evaluate the compatibility of the materials with cells using an indirect method in which growing 
cells are exposed to an extract created by immersing the material in cell culture medium for a 
period of time. 
The most commonly used assays for both of these methods are colorimetric assays that 
depend on a chemical reduction reaction. Using these assays for magnesium materials in a direct 
method leads to a false positive result as the dye is reduced by the electrons released during the 
oxidation of the magnesium substrate itself [29]. Consequently, the indirect method is the most 
popular method for analyzing the biocompatibility of Mg based biomaterials. Although some 
authors have reported analyzing samples exposed to only magnesium (the blank) and then 
subtracting the signal obtained from the samples in the presence of cells, this is still problematic 
because the observed intensity of the magnesium “blank” depends on the corrosion rate of the 
sample [30]. This can be influenced by the mechanism of corrosion of the alloy especially in the 
case of pitting corrosion where high sample to sample variability may be observed. The 
corrosion rate may also be influenced by the presence of the cells themselves.   
The CyQUANT assay used in this study is an excellent alternative as it is an assay based 
on nucleic acid binding and can therefore be used in both indirect and direct biocompatibility 
tests.  In this paper, the results obtained from the direct methods using the CyQUANT assay 
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indicated the ability of Mg AZ31 to promote cell adhesion and cell proliferation over time. 
Moreover, the extremely low fluorescence measurements observed for Mg AZ31 alloys without 
cells indicates that the CyQUANT assay does not yield a false positive result in the presence of 
magnesium. Therefore, this assay provides a better assessment of the overall behaviour of cells 
with Mg based biomaterials because the cells are growing in a direct contact with the biomaterial 
and are therefore exposed to all environmental changes in the cell culture medium, including Mg 
ion release, an increase in pH, hydrogen gas production and the deposition of biodegradation 
products.  
In addition, the CyQUANT assay was also used in an indirect method in this study. The 
results indicated that the Mg alloy conditioned cell culture medium was only slightly cytotoxic to 
the cells.  
The results of this study have demonstrated that the CyQUANT assay can be employed in 
both direct and indirect methods to obtain a more complete analysis of the biocompatibility of 
biodegradable metallic biomaterials.  
3.4 Conclusion 
This research demonstrates that the cyanine dye (CyQUANT assay) can be used to 
evaluate the in vitro biocompatibility of biodegradable magnesium alloys by both direct and 
indirect methods. A particular advantage of this assay is the ability to quantitatively measure cell 
numbers directly on the surface of magnesium biomaterials allowing for a more complete 
evaluation of the behaviour of cells in the presence of all of the degradation products that are 
produced when magnesium alloys biodegrade. The combined results from the direct and indirect 
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biocompatibility tests performed in this study indicate that cell proliferation readily occurs on 
Mg AZ31 surfaces and that the soluble products of biodegradation are only slightly cytotoxic.   
  
78 
 
 
 
References 
1. Parida, P., A. Behera, and S. C. Mishra. "Classification of biomaterials used in medicine." 
International Journal of Advances in Applied Sciences 1.3 (2012): 31-35. 
2. Ratner, B. D., et al. "Biomaterials science." Plasma Processing of Polymers. Netherlands: 
Kluwer Academic Publisher (1997): 453-464. 
3. Malekani, J., et al. "Biomaterials in orthopedic bone plates: a review." Proceedings of the 
2nd Annual International Conference on Materials Science, Metal & Manufacturing (M3 
2011). Global Science and Technology Forum (2011): 71-77. 
4. Staiger, M. P., et al. "Magnesium and its alloys as orthopedic biomaterials: a review." 
Biomaterials 27.9 (2006): 1728-1734. 
5. Yang, J. X., et al. "In vivo biocompatibility and degradation behavior of Mg alloy coated 
by calcium phosphate in a rabbit model." Journal of Biomaterials Applications 27.2 
(2012): 153-164. 
6. Song, G., and A. Atrens. "Recent insights into the mechanism of magnesium corrosion 
and research suggestions." Advanced Engineering Materials 9.3 (2007): 177-183. 
7. Han, H.S., et al. "Conventional and improved cytotoxicity test methods of newly 
developed biodegradable magnesium alloys." Metals and Materials International 21.6 
(2015): 1108-1117. 
79 
 
 
 
8. International Organization for Standardization, ISO 10993-5. "Biological evaluation of 
medical devices-Part 5: Tests for in Vitro Cytotoxicity." (2009): 10993-5.  
9. International Organization for Standardization, ISO 10993-12. "Biological evaluation of 
medical devices-Part 12: Sample preparation and reference materials." (2012): 10993-
109912. 
10. Fischer, J., et al. "Interference of magnesium corrosion with tetrazolium-based 
cytotoxicity assays." Acta Biomaterialia 6.5 (2010): 1813-1823. 
11. Jones, L. J., et al. "Sensitive determination of cell number using the CyQUANT® cell 
proliferation assay." Journal of Immunological Methods 254.1-2 (2001): 85-98. 
12. Armitage, B. A. "Cyanine dye-DNA interactions: intercalation, groove binding, and 
aggregation." DNA Binders and Related Subjects. Springer, Berlin, Heidelberg, 2005. 55-
76. 
13. Bruijns, B. B., Roald M. T., and Johannes GE G. "Fluorescent cyanine dyes for the 
quantification of low amounts of dsDNA." Analytical Biochemistry 511 (2016): 74-79. 
14. Shindy, H. A. "Fundamentals in the chemistry of cyanine dyes: A review." Dyes and 
Pigments 145 (2017): 505-513. 
15. Agha, N. A., et al. "The degradation interface of magnesium-based alloys in direct contact 
with human primary osteoblast cells." PloS One 11.6 (2016): e0157874. 
80 
 
 
 
16. Zheng, Y. F., X. N. Gu, and F. Witte. "Biodegradable metals." Materials Science and 
Engineering: R: Reports 77 (2014): 1-34. 
17. Witte, F. "The history of biodegradable magnesium implants: a review." Acta 
Biomaterialia 6.5 (2010): 1680-1692. 
18. Witte, F., et al. "Biodegradable magnesium scaffolds: Part II: Peri‐implant bone 
remodeling." Journal of Biomedical Materials Research Part A 81.3 (2007): 757-765. 
19. Witte, F., et al. "In vivo corrosion of four magnesium alloys and the associated bone 
response." Biomaterials 26.17 (2005): 3557-3563. 
20. Li, Z., et al. "The development of binary Mg-Ca alloys for use as biodegradable materials 
within bone." Biomaterials 29.10 (2008): 1329-1344. 
21. Pietak, A., et al. "Bone-like matrix formation on magnesium and magnesium 
alloys." Journal of Materials Science: Materials in Medicine 19.1 (2008): 407-415. 
22. Wang, Y., et al. "Corrosion process of pure magnesium in simulated body 
fluid." Materials Letters 62.14 (2008): 2181-2184. 
23. Willumeit, R., et al. "Chemical surface alteration of biodegradable magnesium exposed to 
corrosion media." Acta Biomaterialia 7.6 (2011): 2704-2715. 
24. Gordon, J. A., et al. "Bone sialoprotein expression enhances osteoblast differentiation and 
matrix mineralization in vitro." Bone 41.3 (2007): 462-473. 
81 
 
 
 
25. Neve, A., A. Corrado, and F. P. Cantatore. "Osteoblast physiology in normal and 
pathological conditions." Cell and Tissue Research 343.2 (2011): 289-302. 
26. Müller, W. E., et al. "Mineralization of bone‐related SaOS‐2 cells under physiological 
hypoxic conditions." The FEBS Journal 283.1 (2016): 74-87. 
27. Strzelecka-Kiliszek, A., et al. "Characteristics of minerals in vesicles produced by human 
osteoblasts hFOB 1.19 and osteosarcoma Saos-2 cells stimulated for 
mineralization." Journal of Inorganic Biochemistry 171 (2017): 100-107.  
28. Li, L., et al. "Corrosion and biocompatibility improvement of magnesium-based alloys as 
bone implant materials: a review." Regenerative Biomaterials 4.2 (2017): 129-137. 
29. Walker, J., et al. "Magnesium biomaterials for orthopedic application: a review from a 
biological perspective." Journal of Biomedical Materials Research Part B: Applied 
Biomaterials 102.6 (2014): 1316-1331. 
30.  Charyeva, O., et al. "Biocompatibility of magnesium implants in primary human reaming 
debris-derived cells stem cells in vitro." Journal of Orthopaedics and Traumatology 17.1 
(2016): 63-73. 
82 
 
 
 
Chapter 4  
4 Development of a Biocompatible Calcium Phosphate Coating 
with Improved Degradation Resistance for Biodegradable 
Magnesium Implant Materials 
 
 
 
 
 
 
Afrah Al Hegy, Joy Gray-Munro, Eric R. Gauthier 
Dept. of Chemistry and Biochemistry and Materials Science Program, Laurentian 
University, Sudbury, Ontario, Canada, P3E 2C6 
 (Manuscript) 
 
 
 
  
83 
 
 
 
Abstract  
In recent years, there has been growing interest in using magnesium alloys as a new 
generation of biodegradable materials for orthopaedic applications. However, the rapid 
degradation of magnesium in physiological environments has prevented its widespread use in 
medicine. Therefore, surface modification with coatings that slow the degradation rate while also 
enhancing the biocompatibility of magnesium alloys are of significant interest. In this study, a 
multilayer coating system consisting of a sol-gel silica layer followed by a mesoporous silica 
layer and finally a layer of calcium phosphate was designed to meet this goal.   
The coating conditions were optimized and the surface characterization results indicate that the 
multilayer coating of silica sol-gel, mesoporous silica, and calcium phosphate was successfully 
deposited on magnesium AZ31 alloy. The results from the corrosion test in NaCl solution 
demonstrate that the optimized multi-layer coating has excellent corrosion resistance. The in 
vitro biodegradation test in physiological solutions confirmed that the multi-layer coating 
provides an effective protection for the Mg alloy substrate from rapid degradation. Moreover, the 
cytotoxicity tests showed that the protective layer has no cytotoxic effect on Saos-2 osteoblast 
cells. These in vitro studies confirm that the use of multi-layered coatings consisting of sol-gel 
silica and calcium phosphate is an effective strategy for controlling both the degradation rate and 
biocompatibility of magnesium alloys for medical applications. 
Keywords: Magnesium alloys, biodegradation, surface modification, mesoporous silica, calcium 
phosphate 
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4.1 Introduction 
In recent years, magnesium and its alloys have received much attention as potential 
orthopaedic biomaterials due to their excellent biocompatibility, biodegradability, and 
mechanical properties that are similar to natural bone. These properties have made magnesium 
alloys a promising alternative for biodegradable orthopaedic implants that decrease stress 
shielding and enhance new bone growth [1]. The biodegradability of magnesium provides a good 
advantage for short term implants that are no longer necessary after healing because the need for 
a second surgery to remove the implant is eliminated. Unfortunately, the degradation rate of 
magnesium is fast due to its high chemical and electrochemical reactivity [1,2]. This high 
degradation rate may result in the loss of implant strength prior to healing. Therefore, the main 
goal of this study was to create a non-cytotoxic, multi-layered coating to control the degradation 
rate of magnesium alloys in body fluids.    
Many articles have discussed the formation of a covalently bonded protective silica layer 
on a variety of substrates such as magnesium alloys, aluminum alloys, iron, stainless steel and 
other metals [3,4,5]. Vasconcelos and his group have demonstrated that sol-gel silica coatings 
can provide good corrosion protection for stainless steel in a simple salt solution containing 3.5% 
NaCl [5]. Consequently, a sol-gel silica layer was chosen as the first layer of the multilayer 
system. It was expected that this layer would not only enhance corrosion resistance but would 
also improve the adhesion of the mesoporous silica particles by providing Si-OH surface 
functional groups on magnesium that can undergo a condensation reaction with the Si-OH 
groups on the surface of the mesoporous silica particles thus forming a strong covalent bond 
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between the particles and the magnesium surface. The interaction of silane with metal surfaces 
occurs in two steps according to the sol-gel process. The first step is the hydrolysis of the silane. 
This occurs when the alkoxy groups react with water to form reactive silanol groups (Si-OH). 
The second step is the condensation of silane molecules. In this step, the silanol groups can react 
with each other to form siloxane bonds (Si-O-Si) or they can react with surface hydroxyl groups 
to form Si-O-Metal bonds. These reactions are shown in reaction scheme 4.1 below: 
Reaction Scheme 4.1: Silane Chemistry 
 
1- The hydrolysis of the silane molecules - (sol formation) 
 Si(OR)4 + 4H2O                              Si(OH)4  + 4ROH 
2- The condensation of the silane molecules - (gel formation)                       
                                                                             OH            OH           
        Si(OH)4  +  Si(OH)4                        HO –– Si –– O –– Si –– OH  + H2O 
                                                                             OH            OH    
3- The formation of a silane film on metal surfaces                                                                                                          
         OH                         OH                                                       OH            OH          
HO –– Si –– OH  HO –– Si –– OH                                  HO –– Si –– O –– Si –– OH + 2H2O 
          OH                         OH                                               O               O  
          OH                         OH                                              
Self-assembly of the silane film 
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The second layer is a spin-coated mesoporous silica layer. Mesoporous silica is an 
inorganic material synthesized in the presence of a surfactant or a block co-polymer, which acts 
as a template, and a silica precursor molecule. Porous materials have been classified by IUPAC 
according to their pore size; macropores have a diameter greater than 50 nm, micropores have a 
diameter less than 2 nm and mesopores have a diameter from 2-50 nm. Mesoporous silica 
materials are synthesized through a combination of the sol-gel processes and self-assembly of the 
surfactant. A silicate-surfactant species is formed followed by condensation of the siloxane 
network to form hexagonal arrays and finally the surfactant is removed to produce the 
mesoporous structure [6]. Mesoporous silica materials have begun to attract attention for 
biomedical applications due to their high surface areas, high pore volumes, and good 
biocompatibility [6]. Mesoporous silica materials have been used as a biomaterial coating on 
different substrates such as titanium, glass and stainless steel due to its biocompatibility, 
bioactivity, and its ability to be used as a drug-delivery coating [7,8,9]. For example, Ehlert and 
his co-workers have successfully developed a local drug delivery and biocompatible coating on 
glass by using mesoporous silica that was loaded with the antibacterial drug ciprofloxacin to 
prevent bacterial infections after implantation [9]. These materials have been shown to have 
good bioactivity and the ability to stimulate osteoblast proliferation and differentiation at implant 
surfaces. Furthermore, they have been shown to be non-toxic and non-inflammatory to 
mammalian tissues. Gomez-Vega et al. have indicated that mesoporous silica coatings on 
different substrates (glass, silicon, and titanium), can form apatite when they are immersed in a 
simulated body fluid [7]. Also, Wang et al. used a mesoporous bioactive glass coating on 
stainless steel to improve implant-bone integration. The authors reported that the mesoporous 
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structure of the coating was responsible for protein adsorption followed by osteoblastic cell 
attachment, proliferation and differentiation [8]. The toxicity and the mechanism of excretion of 
mesoporous silica materials in vivo were also investigated by injecting mesoporous silica 
particles into a live mouse tail which did not show any evidence of toxic effects during the one 
month study and the particles of silica were excreted in the urine [10]. The spin-coating 
technique has been widely used to prepare mesoporous silica coating on many different 
substrates including glass, silicon and titanium [7,11,12]. Compared to other techniques, spin-
coating has several advantages including thin and uniform coating thickness, a low volume of 
solution is needed for each sample, fast evaporation of solvent and it is a rapid procedure 
[11,13,14].  
The final layer of the coating is a calcium phosphate layer. Biocompatible ceramics such 
as calcium phosphates are biodegradable inorganic coatings that can be used to enhance the 
corrosion resistance of metallic implants as well as to improve their surface bioactivity. Calcium 
phosphate has been used as a coating due to its bioactivity, excellent biocompatibility, non-
toxicity, and bone inductivity [15]. It has previously been used as a coating on titanium in order 
to improve osteointegration and osteoconductivity [16,17]. Recently, calcium phosphate coatings 
have been used as a protective coating on magnesium alloys [15,18]. Cui et al. reported that a 
Ca-P coating significantly decreased the degradation rate of AZ31Mg alloy in 3.0% NaCl 
solution and was very effective in protecting the substrate from rapid degradation [15]. 
Moreover, Xu et al. evaluated the in vitro and in vivo behaviour of the surface bioactivity of a 
calcium phosphate coated magnesium alloy. In vitro cell evaluation results showed that cells had 
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good adherence and proliferation on the Ca-P-coated magnesium alloy thus demonstrating that 
Ca-P coatings can provide excellent biocompatibility for magnesium alloys. In vivo studies of a 
calcium phosphate coated magnesium alloy demonstrated that the Ca-P coating provided the 
magnesium alloy with good bioactivity and promoted early bone growth at the implant/bone 
interface [19].  
The objective of this study was to develop a surface modification strategy for magnesium 
alloys that controls both the degradation rate and the biocompatibility of these materials. In this 
project, a multilayer system has been developed for this purpose. The multilayers consist of: 
 1) an initial sol-gel silica layer to enhance corrosion resistance 
 2) a spin coated mesoporous silica layer to enhance the stability of the subsequent calcium 
phosphate layer through ingrowth of the calcium phosphate film into the pores of the 
mesoporous particle layer 
3) a layer of calcium phosphate to improve the corrosion resistance as well as provide optimum 
biocompatibility of the magnesium substrate 
4.2 Material and Methods 
4.2.1 Materials 
  Mg AZ31 foil (0.81 mm thickness) was purchased from Alfa Aesar (US). 
Tetraethoxysilane (TEOS), sodium hydroxide, ammonium hydroxide, 
dodecyltrimethylammonium chloride, calcium phosphate monobasic and Hanks Balanced salt 
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solution (Table 4.1) were purchased from Sigma-Aldrich (Canada). Acetone (reagent grade) was 
purchased from Caledon Laboratory Chemicals (Canada). Bovine Calf Serum (BCS) was 
purchased from Fisher Scientific (Canada). McCoy’s 5a and Trypsin/EDTA (1X) were 
purchased from Corning (Canada). Phosphate Buffered Saline (PBS) (1X) and Penicillin-
Streptomycin Solution were purchased from HyClone (Canada). CyQUANT cell proliferation 
assay was purchased from Life technologies (Canada). Ethyl alcohol (95%) and methanol were 
purchased from Commercial Alcohols (Canada). All chemicals were used as received without 
further purification. The Saos-2 cell line was purchased from American Type Culture Collection 
(US) and cultured for further experiments. 
Table 4.1: Composition of Hanks Balanced Salt Solution. 
Component Concentration (g/L) 
CaCl2. 2H2O 0.185 
MgSO4 (anhyd) 0.09767 
KCl 0.4 
KH2PO4(anhyd) 0.06 
NaHCO3 0.35 
Na2HPO4(anhydrous) 8.0 
D-Glucose 0.04788 
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4.2.2 Sample Preparation 
The AZ31 magnesium alloy was cut into circular discs with a diameter of 1.27 cm and 
then polished to a one-micron surface finish to remove the gross oxide layer. In order to clean 
and remove any excess polishing oil from the surface of the alloys, they were sonicated in 
acetone for 20 minutes and then rinsed in deionized water for 30 seconds. Then, the samples 
were immersed into an alkaline bath (0.05 M NaOH, pH 12.5) at 50 °C for one hour to promote 
the formation of surface hydroxyl groups.  
4.2.3 Coating Processes 
An overview of the coating process used is shown in Schematic Diagram 4.1. In brief, the 
magnesium alloy AZ31 samples were polished, cleaned and alkaline aged. A multi-layer coating 
was then deposited on the substrate. The multilayers consist of an initial sol-gel silica layer, 
followed by a spin coated of mesoporous silica layer and finally a layer of calcium phosphate. 
91 
 
 
 
 
Schematic Diagram 4.1: An Overview of the Coating Process 
 Sol-gel Silica Layer 
The silane coating solution was prepared by using a 6% (v/v) TEOS, 14% (v/v) deionized 
water, 6% (v/v) ammonium hydroxide, and 74% (v/v) methanol as a solvent. The solution was 
allowed to stir for 24 hours to ensure complete hydrolysis before coating. Then the samples were 
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immersed in the solution for 20 min. After coating, the samples were dried before curing in an 
oven for 1h at 100 °C. 
 Mesoporous Silica Layer 
The mesoporous silica layer was spin-coated from solution onto the magnesium substrate. 
The mesoporous silica coating solutions were prepared by using TEOS as a silica precursor and 
the cationic surfactant C12TAC (dodecyltrimethylammonium chloride) as the templating agent in 
deionized water, ammonium hydroxide, and methanol as the solvent. The molar ratio of TEOS: 
C12CAT: deionized water, methanol, and ammonia was 1:0.4:774:1501:72. Therefore, 100 mL of 
methanol was mixed with 0.248 g of C12TAC, 17.7 mL of deionized water, 8 mL of 28% 
aqueous ammonia solution and 0.368 mL of TEOS. The solution was pre-hydrolyzed for 1h prior 
to spin coating. Subsequently, 100 μL of the coating solution was pipetted onto the substrate, 
which were spun for a minute at 2000 rpm. This process was repeated until the required number 
of layers was deposited. The samples were cured for 1h after coating. To remove the surfactant, 
the coated samples were calcined at 350°C for 3h. 
 Calcium Phosphate Layer 
The calcium phosphate layer was deposited by dip coating the sol-gel silica+mesoporous 
silica coated substrates in an aqueous calcium phosphate solution. The calcium phosphate 
coating solution was prepared by dissolving monocalcium phosphate (Ca(H2PO4)2) in deionized 
water (pH ~ 4.5); the solution was stirred overnight to ensure complete dissolution.  
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 The Mg AZ31 samples were immersed into 25 mL of the calcium phosphate solution; 
both 3 mM and 6 mM concentrations were tested. The coating process was further optimized as a 
function of deposition time (1, 3, and 7 days) to determine the best coating conditions for a stable 
and uniform calcium phosphate layer on the surface of the mesoporous silica coated magnesium 
alloy. After coating, the samples were rinsed with deionized water and then air dried. 
4.2.4 Magnesium Release Rate in NaCl Solution 
The degradation rate of the coated samples compared to uncoated Mg AZ31 was 
evaluated by monitoring the amount of magnesium released into solution as a function of time 
upon immersion in 3.5% (w/v) NaCl solution at room temperature. The samples were mounted in 
epoxy to ensure a uniform surface area and surface chemistry for the corrosion test. Each sample 
was immersed in 40 mL of NaCl solution. At 24 hour intervals, the solutions were mixed well 
and a 100 μL aliquot was taken from the solution and diluted to 10 mL in a 2% nitric acid 
solution. The concentration of magnesium in the diluted solutions was determined using flame 
atomic absorbance spectroscopy with a Perkin Elmer AA analyst 400 spectrometer. 
Quantification was performed using a calibration curve of known concentrations of magnesium 
(0.05, 0.1, 0.2, and 0.5 mg/L).  
4.2.5 In Vitro Degradation Study in Simulated Body Fluid (SBF) 
To compare the degradation rates of the coated samples to the uncoated magnesium alloy, 
the concentration of magnesium ions was measured as a function of time by flame atomic 
absorbance spectroscopy as described in section 4.2.4. The mounted samples were immersed into 
40 mL of Simulated Body Fluid (SBF). The samples were stored at 37 °C to mimic in vivo 
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conditions according to ASTM standard. The solutions were changed daily over a one week 
period. Each day, a 100 µL aliquot was taken from the solution, diluted to 10 mL with 2% HNO3 
in a volumetric flask and processed for the flame atomic absorbance spectroscopy. Finally, the 
samples were removed from the solution after seven days and they were rinsed with deionized 
water. The samples were dried prior to further analysis. 
4.2.6 Cytotoxicity Test 
 The cytotoxicity was evaluated using an indirect method: already growing cells were 
exposed to a magnesium alloy conditioned culture medium prepared by incubating the uncoated 
and coated magnesium samples in cell culture medium for 72 hours at 37oC in a 5% CO2 
atmosphere. 
 Preparation of Magnesium Alloy Conditioned Extract 
 Prior to the cytotoxicity experiment, all samples were sterilized in 70% ethanol for 10 
minutes followed by washing with warm (37oC), sterile PBS. The uncoated and coated Mg alloys 
were placed in a 24-well plate that contained cell culture medium only (2 mL of McCoy’s 
medium/ per well) and then incubated for 72 hrs at 37oC in a 5% CO2 atmosphere. Then, the 
conditioned medium was used for the indirect test. 
 Cell Culture  
 Human osteosarcoma Saos-2 cells were cultured in McCoy’s 5a cell culture medium 
containing 15% Bovine Calf Serum and 1% penicillin/streptomycin at 37oC in a 5% CO2 
atmosphere. The cell culture medium was changed every two days. Once the cells grew to about 
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70-80% confluence, they were washed with PBS and detached from the flask with 
Trypsin/EDTA and then centrifuged at 2500 rpm for 5 minutes. The supernatant was discarded, 
and the cells were resuspended in fresh McCoy’s medium. The number of cells in the suspension 
was determined by the trypan blue dye using a Neubauer hemocytometer. Then, the cells were 
used for the indirect experiment.  
 Indirect Test 
 15,000 cells were seeded in a 96-well plate in triplicate for each sample type. Cells were 
incubated at 37℃ in a 5% CO2 for 24 hours to allow attachment to the plate surface. After 24 
hours of incubation, the cell culture medium was removed and replaced by 200 µL of the 
magnesium conditioned medium. The plate was then incubated for another 24 hrs at 37℃ in a 
5% CO2 atmosphere. After 24 hrs, the magnesium conditioned media were removed, the cells in 
the 96-well plates were rinsed with warm PBS in order to remove non-adherent cells, and the 
plate was frozen at -20ºC at overnight for the cells to lyse. Cells cultured in fresh, non-
conditioned medium was used as a control group. 
 Cytotoxicity Assay 
 The cell numbers were determined using the CyQUANT assay. The CyQUANT assay 
does not depend on a reaction with cellular metabolic products as other assays do but rather on 
the interaction of a dye with the cellular nucleic acids. The cell numbers can be determined by 
measuring the fluorescence intensity of the DNA-bound dye.  
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 The CyQUANT assay was used according to the supplier’s instructions. 200 µL of 
CyQUANT solution was added to each sample and incubated for 5 minutes. At the end of the 
incubation period, 100 µL of the CyQUANT solution was pipetted from each well to a black 
fluorescent 96-well plate (Costar) and the fluorescence intensity of each solution was measured 
with a Fluostar Optima spectrofluorometer. The cell number was then determined using a 
calibration curve of known number of cells vs. fluorescence intensity. The experiment was 
repeated two times to ensure the reliability of the results. The experiments were run on different 
days in triplicate. Uncoated and coated samples were analyzed in comparison to the control (cells 
grown in non-conditioned cell culture medium).   
The cell viability was reported as a percentage of the number of viable cells in the 
presence of magnesium conditioned extract in cell culture media in comparison to the number of 
viable cells in the absence of magnesium extract in cell culture media (control). The cell viability 
percentage was calculated as the following equation: 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦% = (
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑡𝑜 𝑀𝑔 𝑒𝑥𝑡𝑟𝑎𝑐𝑡
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑠𝑎𝑚𝑝𝑙𝑒
) ∗ 100 
4.2.7 Surface Characterization 
 Attenuated Total Reflection Fourier Transform Infrared 
Microscopy (ATR-FTIR) 
Attenuated total reflection Fourier transform infrared microscopy (ATR-FTIR) was used 
to analyze the surface of the alloys after each step to determine the chemical functional groups 
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on the surface of the coated Mg alloys. A Bruker Optics Hyperion infrared microscope equipped 
with an attenuated total reflectance objective and a germanium crystal was employed. The 
resolution of the spectrometer was 4 cm−1 and 100 scans were taken per spectra. Spectra were 
collected at three spots for each sample. The spectra were corrected with the atmospheric 
compensation function of the OPUS software to remove water vapour and CO2 from the spectra.  
In addition, the baseline for each spectrum was corrected using the OPUS software. 
 Atomic Force Microscopy (AFM) 
Atomic force microscopy (AFM) was used to characterize the surface morphology of the 
as-deposited mesoporous silica coatings on the surface. A Bruker multimode AFM III D was 
used to capture the images in tapping mode. Bruker AFM TESPA probes with a resonant 
frequency of approximately 320 KHz were used. An image area of 5 μm x 5 μm was scanned at 
a scan rate of 0.5 Hz and 512 samples/line. The images were flattened using the Nanoscope 
Analysis software and are presented without any further modification. 
 Scanning Electron Microscopy and Energy Dispersive X-ray 
Spectroscopy (SEM-EDS) 
Scanning electron microscopy and energy dispersive X-ray spectroscopy (SEM-EDS) 
were used to evaluate the surface morphology and surface chemical composition of the samples.   
SEM images were obtained using a JEOL 6400 field emission SEM operated at 20kV, 1 nA and 
10-6 Torr. An Oxford EDS detector was used to determine the elemental composition of the 
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sample surface. Samples to be analyzed were coated with a thin film of carbon to render the 
sample conductive.  
 Flame Atomic Absorption Spectroscopy (FAAS)  
 Flame atomic absorption spectroscopy (FAAS) was performed with a Perkin Elmer AA 
analyst 400 spectrometer. This technique was used to measure the concentration of magnesium 
ions that had been released into the solution during the degradation tests. The concentration 
measurements were done by using a calibration curve for standards of known concentrations of 
magnesium (0.05, 0.1, and 0.2 mg/L). An SBF control set was used to compare the 
concentrations of magnesium ions in the SBF solution with the solutions that had been exposed 
to the coated and uncoated magnesium alloy. The samples for analysis were prepared as 
previously described in sections 4.2.4 and 4.2.5. 
4.3 Results and Discussion 
4.3.1 Optimization of the Multi-layered Coating Conditions 
Surface modification is one of the most effective ways to create an optimum 
biodegradable orthopedic implant. In this study, a multi-layered biocompatible and protective 
coating surface was developed to control the biodegradation rate and improve the surface 
biocompatibility of a magnesium alloy. The surface chemistry and morphology of each layer was 
characterized and the conditions were optimized to give a final multilayered coating with the 
optimized degradation resistance. This was determined by immersing the samples in a 3.5% 
sodium chloride solution for up to one week and comparing the amount of magnesium released 
99 
 
 
 
for the coated samples in comparison to the control samples. The multilayered coating that gave 
the lowest magnesium release was designated as the best overall coating.   
 Deposition of the Sol-Gel Silica Coating (Layer 1) 
In order to enhance the corrosion resistance of the Mg alloy and improve the adhesion of 
the mesoporous silica particles (layer 2) on the surface, a sol-gel silica layer was deposited. This 
layer is capable of covalently bonding to the magnesium alloy surface through the formation of 
Mg-O-Si groups via a condensation reaction between the silanol groups of the hydrolyzed TEOS 
molecules and surface Mg-OH functional groups. In addition, silanol (Si-OH) present at the 
surface of this coating can covalently bond to the mesoporous silica particles through a 
condensation reaction between the silanol groups at the surface of the coating and the silanol 
groups on the surface of the mesoporous silica particles. The surface chemistry and morphology 
of the as-deposited sol-gel silica coated samples were characterized by infrared microscopy and 
high-resolution scanning electron microscopy (HRSEM), respectively. 
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Figure 4.1: IR Spectra of Mg Alloy Before and After Coating with Sol-gel Silica (TEOS 
Concentration 6% (v/v), Deposition Time 20 Minutes). (a) Polished Magnesium Alloy AZ31 
before coating (Control) and (b) Sol-gel Silica Coated Magnesium Alloy AZ31. 
Figure 4.1 shows representative infrared spectra for the Mg alloy before and after coating 
with sol-gel silica. The surfaces of the magnesium alloy samples were polished, cleaned and 
alkaline aged prior to coating. Figure 4.1 (a) shows an IR spectrum of Mg AZ31 alloy after 
(b) 
(a) 
Si-O 
Mg-OH 
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surface pre-treatment. This spectrum has a sharp peak (O-H stretch) at 3700 cm-1 which indicates 
the presence of crystalline Mg(OH)2. The formation of hydroxyl groups on the surface of the 
magnesium alloy is very important for covalent bond formation between the metal and the sol-
gel silica coating. Moreover, a broad peak (O-H stretch) from 3000 to 3500 cm-1 and a peak (O-
H bend) at 1640 cm-1 were observed which can be attributed to either surface adsorbed water 
and/or non-crystalline magnesium hydroxide on the surface. A carbonate (CO3
2-) peak is also 
observed at 1450 cm-1 due to the reaction of the magnesium surface with carbon dioxide in the 
atmosphere. In addition, despite the extensive cleaning regimen, peaks at 2850-2930 cm-1 
(CH2/CH3 stretch) were also observed indicating that a small amount of organic contamination is 
still present on the surface after the pre-treatment process. 
Figure 4.1 (b) shows a representative infrared spectrum of the sol-gel silica coated 
magnesium alloy prepared by immersing the pretreated magnesium alloy sample in a 6% (v/v) 
TEOS solution for a deposition time of 20 minutes. These specific coating conditions for the sol-
gel silica layer were chosen based on our previous studies which had demonstrated that high 
TEOS concentration coupled with long deposition time resulted in non-uniform films whereas 
high TEOS concentration with low deposition time produced sol-gel silica film with good 
thickness and uniformity that can be employed as a protective layer on Mg alloys [20]. 
As shown in Figure 4.1 (b), a new broad peak was observed after coating at 1050-1250 cm-1 
which is attributed to the Si-O stretch and confirms the condensation of the hydrolysed TEOS to 
form a sol-gel silica coating on the surface of the magnesium alloy. It was also observed that the 
intensity of both the Mg(OH)2 peak at 3700 cm
-1 and the carbonate peak at 1450 cm-1 decrease. 
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The decrease in intensity of the substrate further confirms the presence of the coating on the 
surface as the sampling depth of the ATR-FTIR technique is limited to a maximum of 1 μm. 
However, this peak at 3700 cm-1 may also be attributed to the presence of silanol (Si-OH) groups 
which would further confirm successful deposition of the sol-gel silica layer. 
 
Figure 4.2: High-Resolution Scanning Electron Microscopy (HRSEM) Image of Sol-gel 
Silica Coated Mg Alloy (TEOS Concentration 6% (v/v), Deposition Time 20 Minutes). 
Figure 3.2 shows a high-resolution SEM image of the sol-gel silica coated magnesium 
alloy surface (6% (v/v) TEOS, deposition time -20 minutes). The image shows that the deposited 
TEOS layer is composed of particles that have an ordered hexagonal structure. An ordered 
hexagonal structure was obtained due to the use of basic catalysis during coating formation. In 
basic catalysis, the hydrolysis rate of the molecules is slower, but the condensation rate is faster 
which leads to the production of compact colloidal particles [21]. The size of these particles is 
approximately 150-200 nm in diameter and they are distributed across the entire surface. 
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Furthermore, all of the sol-gel silica coated samples analyzed have similar morphologies 
indicating excellent sample to sample reproducibility of the coating. 
From the IR spectra and HRSEM image results obtained after the deposition of the sol-
gel silica coating, it is clear that the sol-gel silica layer was successfully deposited with good 
thickness and uniformity. It is therefore an appropriate method to enhance corrosion resistance 
and to improve the adhesion of the mesoporous silica particles by a further condensation reaction 
through the Si-OH at the surface of the sol-gel coating and those on the surface of the 
mesoporous silica particles from layer 2. 
 Optimization of the Mesoporous Silica Coating Conditions (Layer 
2) 
The second layer of the multi-layered coating is a spin-coated mesoporous silica layer. 
This type of coating was chosen due to the possibility of enhanced stability of the subsequent 
calcium phosphate layer due to ingrowth of the calcium phosphate into the pores of the 
mesoporous silica layer. 
4.3.1.2.1 Optimization of the Mesoporous Silica Coating Conditions on 
Bare Magnesium Alloys  
To determine the best coating conditions for the mesoporous silica layer without having 
interference from the underlayer of sol-gel silica, the effect of the number of spin coated layers 
on the structure and uniformity of the mesoporous silica coating was investigated first on bare 
magnesium. The mesoporous silica coated samples were analyzed by infrared microscopy to 
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determine the chemical functional groups on the surface and to ensure the successful deposition 
of the mesoporous silica layer on the surface of the magnesium alloy. Furthermore, atomic force 
microscope (AFM) was used to characterize the surface morphology of the mesoporous silica 
coatings as a function of the number of spin-coated layers. 
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Figure 4.3: IR Spectra for as Deposited Mesoporous Silica Layers on Bare Magnesium 
Alloy as a Function of the Number of Treatments. (a) 3 Spin-treatment, (b) 6 Spin-treatment 
and (c) 9 Spin-treatment of as Deposited Mesoporous Silica Coating. 
An infrared spectrum for the as-deposited mesoporous silica layer on the bare Mg alloy is 
shown in Figure 4.3. There are three peaks of particular interest that can be attributed to the 
presence of the mesoporous silica coating on the surface. The first is the (Si-O) peak at 1050-
(a) 
(b) 
(c) 
Si-O 
CH2/CH3 
Si-OH/Mg-OH 
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1250 cm-1 which indicates the presence of silicate. The second is the (CH2/CH3) stretch at 2850-
3000 cm-1 which confirms the presence of the surfactant in the coating. The third is the sharp 
peak at 3700 cm-1 which may be attributed to either Si-OH or Mg-OH functional groups. From 
Figure 4.3 (a), (b), and (c), It is clear that the deposited mesoporous silica coating is present in all 
cases and the increase in intensity of the Si-O band and surfactant peaks in these spectra 
indicates that the coating thickness increased with an increasing number of spin-treatments. It 
was also observed that the silicate peak at 1050-1250 cm-1 is composed of two overlapping bands 
which demonstrates that as the number of spin-treatments increases, the silane molecules 
efficiently condense with each other to form Si-O-Si bond at 1050 cm-1and also condense with 
magnesium hydroxyl groups on the substrate surface to form Si-O-Mg bond at 1200 cm-1, 
however, this peak at 1200 cm-1 could also be due to an Si-O-C bond indicative of the presence 
of some unhydrolyzed silane molecules. 
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Figure 4.4: AFM Images of Mesoporous Silica Layer on Bare Magnesium Alloys as a 
Function of the Number of Treatments. (a) Uncoated Polished Mg AZ31 (b) 3 Spin-
treatments, (c) 6 Spin-treatments and (d) 9 Spin-treatments of Mesoporous Silica Coating. 
Atomic Force Microscopy (AFM) was used to determine the topography of the 
mesoporous silica layers that were deposited on the surface of the magnesium alloy substrate. 
Figure 4.4 (a) is representative the AFM image of the uncoated, polished magnesium alloy AZ31 
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and shows the polishing grooves on the surface of the substrate. Figure 4.4 b, c, and d show the 
AFM images of the magnesium alloy substrate after 3, 6 and 9 spin-treatments of the 
mesoporous silica coating. Upon comparison to the bare magnesium surface, it is clear that the 
polishing grooves of the magnesium substrate completely disappeared after spin coating due to 
the formation of a spherical particle layer on the surface of the samples. From Figure 4.4 (b, c, 
and d), it is clear the surface density of the mesoporous silica particles increases as a function of 
the number of spin-treatments which correlates with the observed increase in silica peak intensity 
from the infrared spectra in Figure 4.3. It is also clear from image (d) that the surface density of 
spherical particles increases to the point that a uniform layer of mesoporous silica is present on 
the surface. Therefore, 9 spin-treatments was chosen as the best condition to obtain a uniform 
film of mesoporous silica particles on the magnesium alloy substrate.  
4.3.1.2.2 Deposition of the Mesoporous Silica Coating on the Sol-gel 
Silica Layer 
After determining the best coating conditions for the mesoporous silica layer, the two part 
multilayer consisting of mesoporous silica layer on top of the sol-gel silica under layer was 
characterized before and after calcination. The coated samples were calcined at 350°C for 3h in 
order to remove the surfactant and therefore obtain the mesoporous structure.  
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Figure 4.5: IR Spectra of Magnesium Alloy Coated with Sol-gel Silica Layer + 
Mesoporous Silica Layer Before (a) and After (b) Calcination. 
Figure 4.5 shows the infrared spectra of the duplex coating consisting of a first layer of 
sol-gel silica and a second layer of mesoporous silica before and after calcination. The spectrum 
before calcination Figure 4.5 (a) indicates that the multi-layered film has all the peaks that are 
(b) 
(a) 
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indicative of the presence of a sol-gel silica layer and the as-deposited mesoporous silica film on 
the surface of the magnesium alloy.  
In order to obtain the mesoporous structure of the top layer, the surfactant must be 
removed after the coating has been deposited on the surface. From the spectra after calcination 
Figure 4.5 (b), It was observed that the surfactant peaks disappeared completely after calcination 
of the coated magnesium substrate. Moreover, the peak at 3700 cm-1 which is due to the presence 
of either Mg-OH or silanol (Si-OH) peaks has completely disappeared after calcination. Thus, 
this peak can be attributed to the presence of Si-OH bonds due to incomplete condensation 
before calcination; thermal treatment leads to further condensation of the silanol groups 
converting them to silicate Si-O-Si or Si-O-Mg.  
These results confirm the successful deposition of a uniform and thermally stable mesoporous 
silica film on top of the sol-gel silica layer.   
 Optimization of the Calcium Phosphate Coating Conditions (Layer 
3) 
4.3.1.3.1 Deposition of Calcium Phosphate (layer 3) 
To determine the best coating conditions for the calcium phosphate (CaP) layer, the effect 
of varying the coating deposition time and the concentration was studied. The coated samples 
were analyzed by infrared microscopy to compare the thickness and uniformity of the calcium 
phosphate films deposited on the mesoporous silica + sol-gel silica coated magnesium alloys. 
Infrared spectroscopy was also used to identify the chemical composition of the calcium 
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phosphate layer while SEM-EDS was used for characterization of the surface morphology of the 
deposited calcium phosphate layer. 
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Figure 4.6: IR Spectra for Calcium Phosphate Deposited on Mesoporous Silica + Sol-gel 
Silica Coated Mg AZ31 after Immersion in a 3 mM Calcium Phosphate Solution for 
Various Deposition Times. (a) 1 Day, (b) 3 Days and (c) 7 Days Deposition Time in Calcium 
Phosphate Solution. 
(c) 
(b) 
(a) 
HPO42- 
O-H 
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Figure 4.6 shows the IR spectra for calcium phosphate deposited on mesoporous silica 
coated Mg AZ31 from a 3 mM calcium phosphate solution as a function of immersion time. 
After a 1 day calcium phosphate deposition time (Figure 4.6 (a)), the spectrum shows a strong 
peak at 1050-1150 cm-1 which can be attributed to phosphate (PO4
3-) or silicate peaks, both 
phosphorus and silicon were observed in the EDS spectra for this sample type (Table 4.1). The 
spectra after 3 and 7 days deposition (Figure 4.6 (b, c) show three strong peaks at 1122, 1052, 
and 984 cm−1 corresponding to phosphate present as brushite (CaHPO4.2H2O). A sharp peak (O-
H bend) at 1640 cm-1 was also observed and is attributed to the presence of intercalated water 
within the brushite crystal lattice. The two peaks appearing as a doublet at 3527 and 3468 cm−1 
are due to O-H stretch modes of the water in brushite [22,23]. 
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Figure 4.7: IR Spectra for Calcium Phosphate Deposited on Mesoporous Silica Coated Mg 
AZ31 after Immersion in a 6 mM Calcium Phosphate Solution for Various Deposition 
Times. (a) 1 Day, (b) 3 Days and (c) 7 Days Deposition Time in Calcium Phosphate Solution. 
Figure 4.7 shows the IR spectra for calcium phosphate deposited on mesoporous silica 
coated Mg AZ31 from a 6 mM calcium phosphate solution as a function of immersion time. 
From Figure 4.7 (a, b, and c), all the spectra show three strong peaks at 1122, 1052, and 984 
(c) 
(b) 
(a) 
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cm−1 corresponding to phosphate. The three peaks are attributed to the presence of the calcium 
phosphate coating on top of the mesoporous silica coating. This result suggests that the deposited 
calcium phosphate is brushite (CaHPO4.2H2O). However, Figure 4.7 (c) shows that increasing 
the deposition time to 7 days does not have a significant effect on the structure of the calcium 
phosphate layer. Therefore, only 1 day and 3 days deposition time were chosen for further 
optimization studies. 
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Figure 4.8: SEM Images for Calcium Phosphate Deposited on Mesoporous Silica Coated 
Mg AZ31 as a Function of Deposition Time and Concentration of Calcium Phosphate. (a) 1 
Day and (b) 3 Days of Deposition Time in 3 mM Calcium Phosphate Solution.  (c) 1 Day and (d) 
3 Days of Deposition Time in 6 mM Calcium Phosphate Solution. Scale Bar = 500 µm. 
The morphology and elemental composition of the calcium phosphate layer were 
characterized by SEM-EDS. Figure 4.8 shows the SEM images of the calcium phosphate 
deposited on mesoporous silica coated Mg AZ31 as a function of deposition time and 
concentration of calcium phosphate. The SEM images show that the deposited calcium 
a 
d 
b 
c 
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phosphate layer has a plate-like structure that is characteristic of brushite as shown in the 
literature and confirmed by our IR spectroscopy results [24]. 
The image of the calcium phosphate layer deposited with a 1 day deposition time and 3 
mM of calcium phosphate (Figure 4.8 (a)) shows a high variability on the surface due to the 
formation of brushite (a plate-like structure) in some areas while other areas have small nodules 
on the flat surface. However, the atomic percentage of magnesium was very high in these 
samples as shown by the EDS analysis in Table 4.1. This indicates that the deposited calcium 
phosphate layer prepared with 3 mM of calcium phosphate and 1 day of deposition time was thin 
and non-uniform. However, after increasing the deposition time to 3 days (Figure 4.8 (b)), the 
surface was covered with more brushite which indicates that increasing the deposition time may 
increase the uniformity of the deposited calcium phosphate layer. Moreover, significant amounts 
of magnesium and silicon were detected on the flat areas of the 1 day and 3 days CaP coated 
samples prepared in a 3 mM calcium phosphate solution. The SEM images (a and b) coupled 
with the EDS results in (Table 4.1) suggest that the surface was not fully covered by calcium 
phosphate when the coating bath concentration was only 3 mM in calcium phosphate. 
Figure 4.8 (c,d) show the SEM images of the calcium phosphate layer deposited from a 6 
mM calcium phosphate solution. It is clear from these images that the surfaces were completely 
covered with crystalline brushite at the higher concentration as the plate-like brushite structures 
are present over the entire surface. Furthermore, the disappearance of magnesium and silicon 
from the EDS spectra coupled with the increasing calcium atomic percentage indicates that the 
thickness of the calcium phosphate layer increases when the concentration of calcium phosphate 
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in the solution is increased to 6 mM. However, the surface of the deposited calcium phosphate 
after increasing the deposition time from 1 day to 3 days (Figure 4.8 (d)) does not show a 
significant different on the structure and uniformity of the deposited calcium phosphate layer. 
It is clear from the SEM images (Figure 4.8) and EDS analysis (Table 4.1) that the 
thickness and uniformity of the deposited calcium phosphate layer increases with an increase in 
the concentration of calcium phosphate. However, it seems that deposition time does not have a 
significant effect on the thickness of the brushite layer. Therefore, 1 day and 3 day samples 
prepared from a 6 mM of calcium phosphate solution were used for further study to determine 
the stability of the calcium phosphate coating on the mesoporous silica layer. 
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Table 4.2: The Atomic Percentage of Elements after Deposition of Calcium Phosphate on 
Mesoporous Silica Layer. Data are the Average of Three Spots of each Area. 
Atomic % [CaP] 3 mM 6 mM 
Deposition Time 1 day 3 days 1 day 3 days 
Mg  Flat Area 27.4±1.5 16.3±5.7 0 0 
Brushite Area 1.26±1.2 0 0 0 
Si  Flat Area 9.70±1 3.51±0.35 0.21±0.36 0 
Brushite Area 0.70±0.57 0.07±0.06 0.06±0.05 0 
P  Flat Area 9.78±0.96 13.82±0.68 12.49±12.63 7.09±2.73 
Brushite Area 10.57±5.07 14.73±1.77 13.41±1.58 7.20±3.3 
Ca  Flat Area 0.3±0.24 3.60±1.46 40.64±7.57 34.26±10.27 
Brushite Area 16.45±6.76 16.90±6.00 11.65±3.28 13.14±7.51 
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4.3.1.3.2 Magnesium Release Rate in 3.5% NaCl Solution: Selection of 
the Optimum Coating Conditions for the Final Multi-layered 
Coating 
 Poor corrosion resistance is the major issue that has restricted the widespread use of 
magnesium alloys in biomedical application. The chemical and electrochemical reactivity of 
magnesium alloys are considered high when compared with other structural metals such as steel 
and aluminum alloys. The corrosion reaction of pure magnesium proceeds by an electrochemical 
reaction with water as shown in Reaction Scheme 4.2. This reaction produces hydrogen gas, 
magnesium ions and hydroxide ions. This corrosion reaction leads to precipitation of magnesium 
hydroxide at the surface. The film of Mg(OH)2 can provide protection and reduce the corrosion 
rate of magnesium. However, in the presence of chloride anions, this film is readily converted 
into soluble MgCl2 according to Reaction Scheme 4.3 [25]. As the hydroxide layer is converted 
to soluble MgCl2, the underlying substrate is continually exposed to the corrosive media 
resulting in pitting corrosion of the substrate. 
Reaction Scheme 4.2: Corrosion Reaction. 
Mg (s) + 2H2O (l) → Mg(OH)2 (s) + H2 (g) 
Reaction Scheme 4.3: Influence of Anions. 
Mg(OH)2 (s) + 2Cl
-  → MgCl2 (aq) + 2OH- (aq) 
Therefore, an immersion test was performed to determine the best coating conditions for 
the calcium phosphate layer by comparing the amount of magnesium released into a 3.5% NaCl 
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solution as a function of time for the Mg alloys coated with the final multi-layered coating (sol-
gel silica + mesoporous silica + calcium phosphate) and the uncoated material. The samples were 
also analyzed by ATR-FTIR and SEM-EDS after the corrosion test in order to identify the 
corrosion products on the surface. 
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Figure 4.9: Amount of Magnesium Dissolved as a Function of Immersion Time in 3.5% 
NaCl. 1d-Sample (Multi-layered Sample Coated with 6 mM Calcium Phosphate and 1 day 
Deposition Time), 3d-Sample (Multi-layered Sample Coated with 6 mM Calcium Phosphate and 
3 day Deposition Time) and Bare Magnesium (Uncoated Control). 
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Atomic absorption spectroscopy was used to determine the relative corrosion rate of 
unmodified Mg AZ31 in comparison to the multilayer coatings prepared by immersion in a 6 
mM calcium phosphate solution for 1 and 3 days. The samples were immersed in 3.5% NaCl for 
a total of 7 days. The total amount of magnesium dissolved into the NaCl solution during the 
corrosion test was measured daily for the duration of the experiment. Figure 4.9 is a graph of the 
amount of magnesium dissolved into the NaCl solution as a function of immersion time for each 
sample. Each data point represents an average of 3 samples; the error bars are the sample to 
sample standard deviations. Both the 3 day calcium phosphate coated samples and uncoated 
magnesium alloys show a high rate of magnesium release into solution which continued until the 
end of this study. In comparison, the release of magnesium into the solution from the samples 
coated with calcium phosphate for 1 day continued up to 5 days but at a slower rate than the 3 
day coated sample and uncoated sample. The degradation rate was calculated from the slope of 
the plots as shown in Table 4.2.  
Table 4.3: The Degradation Rate of Uncoated and Coated Magnesium Alloys in 3.5% NaCl 
Solution. 
Samples Uncoated Mg 
alloy 
3 days CaP 
coated samples 
1 day CaP 
coated samples 
(0-5 day) 
1 day CaP 
coated samples 
(6-7 day) 
Degradation 
(mg/day) 
0.221 0.226 0.181 0.001 
 
123 
 
 
 
Upon comparison of the 1 day and 3 day coated sample, there is a significant difference 
in the rate of degradation which indicates that the final multi-layered coating with 1day 
deposition time in 6 mM calcium phosphate had a good influence on the corrosion resistance of 
the magnesium alloy. Moreover, it is observed from this study that longer deposition times for 
the calcium phosphate layer does not improve the corrosion resistance of magnesium alloys since 
longer deposition time may lead to partial dissolution of some of the under-layer coatings 
(mesoporous silica and sol-gel layers) during the deposition of calcium phosphate. 
Therefore, it can be concluded that the optimum conditions for deposition of calcium 
phosphate layer on mesoporous silica coated Mg alloys are high calcium phosphate 
concentration (6 mM) and low deposition time (1 day) since this produces a stable, thick and 
uniform layer. Thus, these samples were selected for further characterization. 
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Figure 4.10: IR Spectra for the Final Multi-layered Coating Prepared with 6 mM Calcium 
Phosphate Solution and 1 Day of Deposition Time before and after Immersion in 3.5% 
NaCl Solution. (a) The Final Multi-layered Coating before Corrosion Test, (b) 1 Day, (c) 3 
Days, (d) 7 Days after Corrosion Test 
Figure 4.10 shows infrared spectra for magnesium alloys coated with the final multi-
layered coating before and after immersed in 3.5% NaCl for 1, 3 and 7 days. As shown in this 
(d) 
(c) 
(b) 
(a) 
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figure, the multilayer coating is stable after 1day immersion in 3.5% NaCl. However, after 3 
days in 3.5% NaCl, the three strong peaks that indicate the presence of brushite were gradually 
converted to one broad peak at 1050 cm-1 corresponding to PO4
3-. This may indicate that the 
initial brushite layer is gradually converted to an amorphous calcium phosphate layer.  
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Figure 4.11: SEM Images for Uncoated Control of Magnesium (a, b, c) and the Final Multi-
layered Coating of Calcium Phosphate Deposited on Mesoporous Silica Coated Mg AZ31 
(d, e, f) after 1 Day, 3 Days, and 7 Days Immersion in NaCl Solution. Scale Bar = 500 µm. 
d 
b 
f c 
e 
a 
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Figure 4.11 shows SEM images of the coated and uncoated magnesium alloys after 
immersion in 3.5% NaCl for different times. It is observed from the SEM images (a,b,c) that the 
uncoated sample is completely covered with a layer that is likely magnesium hydroxide and 
soluble magnesium chloride after immersion in 3.5% NaCl as expected due to its high corrosion 
rate. After a 7 day immersion in the 3.5% NaCl solution, the surface of the uncoated magnesium 
alloy was completely covered with a thick layer of magnesium hydroxide or chloride. EDS 
confirmed the presence of magnesium, oxygen and chlorine on the surface of these samples as 
shown in Table 4.3.   
In contrast, the SEM images Figure 4.11 (d,e) for the coated sample after one and three 
days of immersion in 3.5% NaCl, show that the calcium phosphate coating is still present and 
that there are no significant differences in its morphology compared to the coated samples before 
the corrosion test (Figure 4.8 (c)). These images still show the same morphology and the plate-
like structure of brushite that was observed in the as-deposited CaP coating. After seven days of 
immersion in 3.5% NaCl, a layer of calcium phosphate is still observed on the surface of the 
coated samples but with a different morphology. This change in structure occurs as the brushite 
layer is converted to an amorphous calcium phosphate layer after 7 days of immersion in NaCl 
solution as shown in Figure 4.11 (f). However, the gradual decrease of the atomic percentage of 
calcium and phosphate coupled with the increase of the atomic percentage of magnesium on the 
coated surface with increasing immersion time in NaCl solution as shown in Table 4.4 indicates 
the gradual dissolution of the calcium phosphate layer. This mirrors the trend observed for the 
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corrosion rate of the final multi-layer coated samples; as the calcium phosphate layer degrades, 
the corrosion rate increases.  
Table 4.4: The Atomic Percentage of Elements on the Surface of Magnesium Alloy AZ31 
after Corrosion in NaCl Solution. Data are the Average of at least Eight Spots of each Sample. 
Atomic % 1 day 3 days 7 days 
Mg  42.32±4.07 42.95±10.19 42.06±9.55 
O  57.50±4.44 50.95±11.94 56.17±6.38 
Cl  0 2.56±4.12 1.77±3.74 
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Table 4.5: The Atomic Percentage of Elements on the Final Multi-layered Coating of 
Calcium Phosphate Deposited on Mesoporous Silica Coated Mg AZ31 after Corrosion in 
NaCl Solution. Data are the Average of at Least Eight Spots of each Sample. *Due to the 
Changing Morphology of the Coating after 7 Days of Immersion, it was Difficult to Define the 
Flat Areas from the Brushite on the Surface. Therefore the 7-days Results are Reported as One 
Area. 
Atomic % Time 1 day 3 day 7 days (both 
area) 
Mg  Flat Area 1.15±0.0 0 3.83±0.61 
Brushite Area 0.34±0.22 1.21±0.39 
Si  Flat Area 1.78±0.0 0.25±0.35 0.84±1.04 
Brushite Area 0 0.19±0.12 
P  Flat Area 20.62±0.0 7.81±1.25 14.69±1.37 
 Brushite Area 13.19±7.12 10.64±3.45 
Ca  Flat Area 41.26±0.0 56.95±7.80 17.55±4.52 
Brushite Area 41.30±13.98 20.34±14.00 
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4.3.2 Characterization of the Final Multi-layered Coating on Magnesium 
Alloys 
The previous section of this study confirmed the successful production of the 
multilayered coating on the magnesium alloy surface. In the next sections, the cross section of 
the final multi-layered coating, its degradation in simulated biological fluid and its cell 
cytotoxicity were characterized.  
 
 
Figure 4.12: SEM image of the Cross Section of the Final Multi-layered Coating Deposited 
on Magnesium Alloy Substrate.  
Ca, P, O 
Si, Ca, P, O 
Magnesium Alloy Substrate 
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Figure 4.12 shows SEM image of the cross section of the final multi-layered coating on 
magnesium alloys substrate. A cross sectional image was used to observe the homogenous 
formation of the layers on the Mg alloy samples and to determine the thicknesses of the final 
multi-layered coatings. From the cross-sectional view, the thickness of the coating was measured 
to be around 20 μm and the coating was composed of two layers as marked in Figure 4.12. The 
sol-gel silica and mesoporous silica inner layer directly on top of the underlying magnesium 
alloy substrate and the dense outer layer is the calcium phosphate layer. However, The EDS 
analysis also detected the presence of calcium and phosphorus in the inner mesoporous silica 
layer which indicates the ingrowth of the calcium phosphate film into the pores of the 
mesoporous layer. Also, EDS mapping revealed that the calcium and phosphorus were 
homogeneously distributed throughout the inner layer. The ingrowth of the calcium phosphate 
layer into the pores of the mesoporous silica layer may have several advantages including 
increased corrosion resistance and improved adhesion. 
Therefore, a thick, uniform, and stable multi-layered coating was successfully deposited 
on the magnesium alloy substrate. The final multi-layered coating consists of a sol-gel silica 
layer followed by a spin coated of mesoporous silica layer and finally a calcium phosphate 
coating.  
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4.3.3 In Vitro Characterization of the Properties of the Final Multi-layered 
Coating  
Ideal coatings for biodegradable metallic implant materials should enable biodegradation 
at a desired rate and they should only protect the surface for a limited time until the healing 
process occurs [26]. In addition, they must be biocompatible and non-toxic. Depending on the 
intended application the ability to promote osseointegration, bioactivity, antibacterial properties 
or local drug delivery capability may also be very important characteristics.  
Therefore, it is very important to study the in vitro degradation behaviour and 
cytotoxicity of the multi-layered coating to determine the stability and biocompatibility of the 
deposited coating on the biodegradable magnesium alloys in physiological solution.  
 In Vitro Biodegradation Behaviour of the Final Multi-layered 
Coating in Simulated Biological Fluid 
The use of magnesium and its alloys as a biomaterial is promising due to their good 
biocompatibility and mechanical properties. However, their degradation rate is too high in body 
fluids in the first stages of the healing process. Orthopedic biomaterials need around three to four 
months to promote bone regeneration. The fast degradation of magnesium alloy in body fluid can 
lead to the occurrence of a second fracture [2]. Therefore, it is essential to understand the 
biodegradation behaviour of our coated Mg alloy in simulated body fluid (SBF). In vitro 
degradation tests were done by immersing the coated and uncoated samples in SBF at 37 °C for a 
7 day period. The ion concentration and pH of the SBF solution are similar to that of human 
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blood plasma; this solution contains both calcium and phosphate ions which also make it a 
simple test for the ability of a biomaterial to induce calcium phosphate nucleation and growth at 
its surface. Therefore, this experiment was performed to determine the biodegradation rate of Mg 
alloys coated with the final multi-layered coating as well as to identify the biodegradation 
products on the surface.  
One of the expected biodegradation products is the precipitation of calcium phosphate at 
the surface of the alloy. Calcium phosphates have very low Ksp values, especially at elevated pH. 
As the magnesium alloy degrades, the pH rises resulting in precipitation of calcium phosphate 
species. Since the SBF is supersaturated with calcium and phosphate, this reaction readily occurs 
during immersion in the SBF environment. Reaction Scheme 4.4 shows one such precipitation 
reaction that would result in the deposition of hydroxyapatite at the alloy surface [27]. The 
formation of a hydroxyapatite layer on the surface indicates good bioactivity of the implant in 
the physiological solution. This layer can form in direct contact with the surrounding tissue in 
vivo to enhance the osteointegration of the implant and can also improve both the corrosion rate 
and the biocompatibility of magnesium alloys in physiological solutions [27]. 
Reaction Scheme 4.4: Precipitation Reactions. 
10Ca2+ (aq) + 6PO4
3- 
(aq) +2OH
- 
(aq) → Ca10(PO4)6 (OH)2 (s) 
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Figure 4.13: Amount of Magnesium Dissolved as a Function of Immersion Time in SBF for 
the Final Multi-layered Coating (TEOS+MPS+CaP) on Mg AZ31 and Uncoated Control of 
Magnesium (Bare Mg). 
Atomic absorption spectroscopy was used to determine the biodegradation rate of the 
coated Mg alloys in SBF compared to the uncoated material. Figure 4.13 is a graph of the 
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cumulative amount of magnesium dissolved into the SBF solution as a function of time for a 7 
day period.  Each data point represents an average of 3 samples; the error bars are the sample to 
sample standard deviations. The uncoated magnesium alloy started to release magnesium ions 
into solution at a high linear rate which continued to the end of the study. By day 7, an average 
of about 0.71 ± 0.1 mg of magnesium has been released into the SBF solution. In comparison, 
the release of magnesium into the SBF solution from the final multilayered coated sample 
(TEOS+MPS+CaP) continued in a linear fashion as well but at a much slower rate than the 
uncoated sample. Specifically, the coated samples seem to have two linear parts: one starts from 
the beginning of the study up to 4 days which has a very slow degradation rate and the second 
part starts after day 4 up to the end of the study. This high magnesium ion release after 4 days is 
due to an increase in the degradation rate from pitting corrosion. Pitting corrosion was visually 
observed on the sample surfaces. In general, the degradation rate of the coated material increased 
with increasing immersion time which may indicate that the coating is beginning to break down 
as observed from the change in the slope of the plot as a function of immersion time. These 
results are reported in Table 4.5. However, the total amount of magnesium released into solution 
for the coated samples at 7 days is only about 0.249 ± 0.089 for the final multi-layered coating 
(TEOS+MPS+CaP). This suggests that the uncoated samples degrade at a rate that is at least 3 
times greater than the coated samples. Therefore, the final multi-layered coating had a strong 
influence on the corrosion resistance of the magnesium alloy in simulated body fluids.  
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Table 4.6: The Degradation Rate of Uncoated and Coated Magnesium Alloys in SBF 
Solution. 
Samples Uncoated Mg Alloy 
 
Coated Magnesium 
alloy (0-4 days) 
Coated Magnesium 
alloys (5-7 days) 
Degradation Rate 
(mg/day) 
0.106 0.018 0.058 
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Figure 4.14: IR Spectra for the Bare Magnesium (Control) after Immersion in SBF for 
Various Periods of Time. (a) The Bare Magnesium before Biodegradation Test, (b) 1 Day, (c) 3 
Days, (d) 7 Days after Biodegradation Test 
Figure 4.14 shows infrared spectra for the bare magnesium (control) before and after immersion 
in SBF for various periods of time. After 1 day, 3 days and 7 days a new broad peak was 
observed at approximately 1050 cm-1 which confirms the presence of phosphate PO4
3-. 
(d) 
(c) 
(b) 
(a) 
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Moreover, the phosphorus and calcium peaks observed in the EDS spectra confirm that the 
phosphate is due to the presence of a calcium phosphate layer at the surface. This indicates the 
formation of the biodegradation layer on the Mg alloy surface. Furthermore, the Mg(OH)2 peak 
at 3700 cm-1 has disappeared due the formation of this layer on all the surface. No crystalline 
magnesium hydroxide is observed in the corrosion product. A carbonate peak at 1490 cm-1 is 
observed. This may be due to the presence of a mixed corrosion layer containing either calcium 
phosphate and magnesium or calcium carbonate. 
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Figure 4.15: IR Spectra for the Final Multi-layered Coating after Immersion in SBF for 
Various Periods of Time. (a) The Final Multi-layered Coating before Biodegradation Test, (b) 1 
Day, (c) 3 Days, (d and e) 7 Days after Biodegradation Test. Note That Two Type of Spectra 
were Observed after 7 Days of Immersion in SBF (d and e). 
Figure 4.15 shows IR spectra of the final multi-layered coating after immersion in SBF 
for various periods of time. After immersion in SBF, all the samples still have three strong peaks 
(a) 
(b) 
(c) 
(d) 
(e) 
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due to the presence of HPO4
2- from brushite indicating that the final multilayer coating is stable. 
After 7 days of immersion in SBF, a broad peak representing PO4
3- was observed in some spots 
of the sample surface such as the representative one in (Figure 4.15 (e)), indicating the formation 
of a new phase of calcium phosphate. This may be explained by the further deposition of calcium 
and phosphate from the SBF solution at the surface or it may indicate that the brushite layer 
gradually converts to the more stable hydroxyapatite mineral phase. A study by Li et al. showed 
that the brushite coating on a magnesium alloy was transformed into hydroxyapatite after 
immersion in SBF solution [28]. However, in another similar study by Huan et al. no 
hydroxyapatite was formed on the surface of the brushite coating on a Mg alloy after immersion 
in SBF for 7 days [29]. Therefore, different results were obtained from different studies 
depending on the stability of the brushite layer and the increase of the pH value during the 
immersion test. It was reported that brushite (dicalcium phosphate dihydrate) is always 
considered as a precursor for precipitation of hydroxyapatite and increasing the pH during 
immersion can promote the nucleation and growth of hydroxyapatite [28]. In our study, the SBF 
solution was changed every day to mimic physiological conditions; this would keep the pH from 
reaching higher and would therefore delay the transformation of the brushite to hydroxyapatite.  
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Figure 4.16: SEM Images for Uncoated Control of Bare Magnesium (a, b, c) and the Final 
Multi-layered Coating Deposited on Mg AZ31 Alloys (d, e, f) after 1 Day, 3 Days, and 7 
Days Immersion in SBF Solution. Scale Bar = 500 µm. 
a d 
f c 
e b 
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Figure 4.16 shows SEM-EDS images of the coated and uncoated magnesium alloys after 
immersion in SBF for different times. It is observed from SEM images (a,b,c) that the uncoated 
sample is covered with a calcium phosphate layer after immersion in SBF. This was expected 
due to its high degradation rate that creates a high localized pH thus inducing precipitation of 
calcium phosphate at the interface. After 1 day and 3 days immersion in SBF, clusters of calcium 
phosphate and cracks were observed on the surface of the magnesium substrate. After a 7 day 
immersion period in the SBF solution, the surface of the uncoated magnesium alloy was 
completely covered with a thick layer of calcium phosphate. The presence of both calcium and 
phosphorus on these samples surfaces was confirmed by EDS as shown in Table 4.6. The gradual 
decrease in the atomic percentage of magnesium and concomitant increase in the atomic 
percentage of calcium and phosphorus confirms that the thickness of the corrosion product 
increased as a function of immersion time in the SBF.    
 Moreover, the SEM images Figure 4.16 (b, e, f) show the final multi-layered coating 
deposited on magnesium alloys after immersion in SBF. These images confirm the stability of 
the brushite layer that was deposited on the mesoporous silica coating since the images still show 
the platelet structure of brushite even after 7 days of immersion in SBF. The presence of calcium 
and phosphorus and also silicon in the EDS analysis after seven days also confirms the stability 
of the multi-layered coating on magnesium alloys (Table 4.7). 
Furthermore, it was observed from the EDS results that the Ca/P ratio after 7 days on the 
brushite area and flat area increased to 1.22 and 1.44, respectively, which indicates the formation 
of amorphous calcium phosphate due to the further deposition of calcium and phosphate from the 
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SBF solution. This change was also confirmed by the presence of a phosphate peak (PO4
3-) in the 
IR results (Figure 4.15 (e)).  
Thus, the EDS results and the phosphate peaks in the IR spectra suggest that the calcium 
phosphate layer may tend to be transformed into hydroxyapatite layer with longer deposition 
time [28,29]. This conversion should result in a decreased degradation rate since hydroxyapatite 
is less soluble than brushite.    
Table 4.7: The Atomic Percentage of Elements on the Surface of Magnesium Alloy AZ31 
after Immersion in SBF Solution. Data are the Average of at least Eight Spots of each Sample. 
Atomic % 1 day 3 days 7 days 
Mg  69±21.29 22.69±17.37 15.70±9.44 
O  22.06±15.89 52.47±21.47 53.25±16.60 
P  3.57±3.27 12.31±2.92 14.63±4.04 
Ca 2.22±2.07 10.73±2.67 13.58±4.43 
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Table 4.8: The Atomic Percentage of Elements on the Surface of the Final Multi-layered 
Coating Deposited on Magnesium Alloys AZ31 after Immersion in SBF Solution. Data are 
the Average of at least Eight Spots of each Sample. 
Atomic % Time 1 day 3 days 7 days 
Mg  Flat Area 2.33±2.31 0.74±0.45 2.62±1.16 
Brushite Area 0.40±0.51 0.58±0.11 1.06±0.50 
Si  Flat Area 0.45±0.16 1.67±1.08 1.33±0.18 
Brushite Area 0.41±0.34 0.20±0.10 0.02±0.05 
P  Flat Area 20.10±4.87 20.58±5.33 18.16±3.71 
Brushite Area 15.85±5.63 14.97±5.58 16.42±4.23 
Ca  Flat Area 19.54±12.66 40.16±8.73 26.06±14.36 
Brushite Area 19.80±15.78 20.15±10.97 20.16±7.76 
 
 Cytotoxicity Evaluation of the Final Multi-layered Coating:  
 It is well known that the biocompatibility of biomaterials is as important as mechanical 
properties if not more so especially when metallic materials are used. Although magnesium is an 
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essential element for human metabolism and is itself non-toxic, the biocompatibility of 
magnesium and its alloys before and after modification must be investigated to ensure the 
biosafety of the additional elements used in the alloying and the surface modification procedure. 
Cytotoxicity testing is the first step for evaluating the biocompatibility of a new material 
designed for use in biomedical application. In this study, the cytotoxicity was evaluated by an 
indirect method to estimate the impact of the surface modification used in this study on cell 
viability. A magnesium-conditioned cell culture medium were prepared by incubating the 
uncoated and coated magnesium alloys in cell culture media for 72 hrs at 37oC in a 5% CO2 
atmosphere. The cell viability was determined by exposing healthy cells to the conditioned 
medium for 24 hrs. The number of cells was determined using the CyQUANT assay as described 
in section 4.2.6. 
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Figure 4.17: The Percentage of Saos-2 Cell Viability on the Final Multi-layered Coating 
and Bare Magnesium Alloy. Cells Only is the Positive Control. Data are the Average of 6 
Samples (3 Replicates of 2 Independent Experiments). 
 Figure 4.17 shows the effect of coated and uncoated magnesium conditioned media on 
the Saos-2 cell viability. It was observed that the medium conditioned with the coated 
magnesium alloys yielded a cell viability similar to the medium conditioned with uncoated 
magnesium AZ31. No statistically significant difference in the cell viability between the 
uncoated and coated Mg alloys was observed (p > 0.05). The results show that the Mg alloy 
conditioned growth medium of coated and uncoated magnesium alloys have no cytotoxicity 
effect on the osteoblast cells (Saos-2 cell). The ISO definition of cytotoxicity states that a 
material is not cytotoxic unless the cell viability is reduced by more than 30% [30]. The cell 
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viability for both the uncoated Mg AZ31 and the coated Mg AZ31 in this study is reduced by less 
than 20%. This result suggests that all of the components of the multi-layered coating are 
biocompatible and non-toxic. Therefore, the in vitro cell studies demonstrate that the 
cytocompatibility of the multi-layered coating is acceptable for medical implant applications.  
4.4 Conclusions 
From the surface characterization results obtained, it can be concluded that a uniform and 
stable multi-layered coating consisting of silica sol-gel, mesoporous silica, and calcium 
phosphate layers was successfully deposited on magnesium alloy AZ31. Furthermore, the final 
multi-layered coating has good corrosion resistance in 3.5% NaCl solution. The in vitro 
biodegradation study showed that the degradation rate of the coated samples was significantly 
decreased indicating that the multi-layered coating was very effective in protecting the Mg alloy 
substrate from rapid degradation in SBF solution. Moreover, the cytotoxicity evaluation showed 
that the multi-layered coating was not cytotoxic to osteoblast cells. This type of coating may be 
promising for the surface modification of magnesium alloys that exhibit improved degradation 
resistance and biocompatibility and therefore provide a potential biodegradable material for 
application in bone repair.  
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Abstract 
Magnesium and its alloys have been widely investigated as a biodegradable implant 
material for use in fracture fixation devices such as screws, pins and plates. One of the major 
problems associated with using magnesium alloys as orthopaedic biomaterials is their rapid 
degradation in physiological solutions leading to a loss in mechanical properties prior to healing.  
Superhydrophobic surfaces are of interest to control the degradation of these materials due to 
their extreme water repellency, however, they are unsuitable for cell adhesion. In this study, a 
superhydrophobic magnesium alloy surface was modified with a fibronectin mimetic cell 
adhesive molecule. Infrared spectroscopy and contact angle analysis demonstrated that the cell 
adhesive molecule was successfully attached to the surface of superhydrophobic magnesium.  
However, although, fibronectin is a known cell adhesive protein, quantitative analysis of cell 
numbers using the CyQUANT assay indicate that cell adhesion was not enhanced on the surface 
modified material in comparison to the unmodified superhydrophobic magnesium alloy.  
Keywords: Magnesium alloys, biocompatibility, superhydrophobic surface, cell adhesion, 
mussel adhesive protein, fibronectin mimetic 
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5.1 Introduction 
The development of biodegradable metallic biomaterials for orthopaedic applications     
has become of interest in recent years [1]. These materials would provide the necessary stability 
during the initial stages of healing and promote tissue regeneration as they gradually degrade. 
Additionally, biodegradable metals are advantageous because they would eliminate both the 
toxic corrosion products associated with traditional metallic implants and the requirement for a 
second surgery to remove the implants after healing. Magnesium and its alloys are candidates for 
a new generation of biodegradable metallic biomaterials. Magnesium (Mg) and its alloys can 
dissolve or degrade in the body fluid during the healing process. The biodegradation of 
magnesium results in the release of non-toxic magnesium ions that can easily be excreted in the 
urine [2]. As well as its biocompatibility, Mg and its alloys have very similar mechanical 
properties to those of human bone resulting in decreased stress shielding and enhanced growth of 
new bone tissue [3]. However, the rate of magnesium degradation in the human body is normally 
too fast restricting their use in clinical applications. This fast degradation results in the formation 
of hydrogen gas cavities, rapid loss of mechanical integrity, and harmful host tissue reactions 
within the first week after implantation [4]. As biodegradable orthopedic implants, it is necessary 
that the rate of degradation meets the rate of healing of the bone tissue. Thus, it is required for 
the magnesium implant to stay stable for at least 12 weeks [3,4]. Therefore, it is important to 
develop methods to control the surface degradation rate of magnesium biomaterials after 
implantation.  
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Surface modifications play a very important role in the degradation of magnesium alloys 
in the human body. Several strategies for surface modification have been employed to improve 
the degradation rate of magnesium alloys such as chemical conversion coatings, polymer 
coatings, and silane coatings [5,6,7].  
Surface modifications that produce superhydrophobic surfaces are interesting for 
controlling the degradation of these materials due to their extreme water repellency [8]. 
Superhydrophobic surfaces are surfaces with high water contact angles that are greater than 150° 
and low sliding angles (smaller than 5°). The best-known natural example of a superhydrophobic 
surface comes from the lotus leaf. The lotus leaf gets its superhydrophobicity from the 
combination of a hierarchical topography consisting of microscale papillae and a nanostructured 
low surface energy waxy cuticle. The structure of the lotus leaf can be mimicked on man-made 
surfaces to make them superhydrophobic. Generally, superhydrophobic surfaces are produced by 
creating a surface with micro/nanostructured roughness and then modifying the rough surface 
with hydrophobic substances [9,10]. A variety of techniques have been established to fabricate 
superhydrophobic surfaces on magnesium and magnesium alloys such as hydrothermal reaction, 
anodic oxidation, electrochemical deposition, sol-gel polymerization, electrospinning, chemical 
etching, and self-assembly techniques [11,12,13,14,15,16,17]. Zhang et al. fabricated a 
superhydrophobic surface on magnesium alloy AZ31 by the combination of the hydrothermal 
treatment method to get the hierarchical rough structures and post modification with stearic acid. 
The superhydrophobic surface showed a water contact angle of 157.6°. The corrosion results in 
3.5% NaCl showed that the superhydrophobic coatings significantly improved the corrosion 
156 
 
 
 
resistance of the AZ31 alloy [15]. Wang et al. fabricated a layer of flower-like structures on a 
pure Mg surface by chemical etching followed by immersion in a stearic acid solution. The 
superhydrophobic surface showed a water contact angle of 154° with a sliding angle of about 3°. 
The superhydrophobic surface showed four times higher corrosion resistance than pure Mg after 
immersion in a 0.1 mol/L NaCl solution [16]. Furthermore, a study by Xu et al. successfully 
developed a superhydrophobic magnesium (Mg) alloy surface via an electrochemical machining 
process followed by coating with a fluoroalkylsilane film. The results confirmed the production 
of a superhydrophobic surface on the magnesium alloy as evidenced by a water contact angle of 
165.2° and a water sliding angle of approximately 2°. The resulting superhydrophobic surface 
showed excellent corrosion resistance in different acidic solutions, alkaline solutions, and salt 
solutions (3.5 wt % of NaCl, Na2SO4, NaClO3, and NaNO3). In addition, the results of 
immersion in 3.5 wt % NaCl aqueous solution for 24 hrs did not change the superhydrophobicity 
of the surface as the contact angle remained at 160.5° after the test indicating the stability of the 
surface modification [17]. 
In recent years, researchers have focused on the application of superhydrophobic surfaces 
in area of biomaterials for the prevention of protein adsorption and for the prevention of bacterial 
cell growth on biomaterials. Pernites et al. prepared a superhydrophobic polythiophene film on 
various substrates resulting in the inhibition of both protein adsorption and bacteria cell adhesion 
to the surface [18]. Furthermore, Moradi et al. investigated the effect of superhydrophobicity on 
platelet adhesion to stainless steel and titanium substrates. The results showed that 
superhydrophobic surfaces are highly resistant to platelet adhesion demonstrating that 
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superhydrophobic surfaces on metals offer a novel method to improve the hemocompatibility of 
metallic substrates [19]. 
In the present study, the hierarchical surface topography and extreme water repellency 
has been reproduced on a Mg AZ31 surface via a combination of acid etching of the substrate 
followed by coating with a hydrophobic polysiloxane layer as described by Gray-Munro and 
Campbell [20]. The acid etching produced microscale features that are further described in the 
results and discussion section. The polysiloxane coating was produced by polymerization of 
poly(dimethylsiloxane) (PDMS) with 3-mercaptopropyltrimethoxysilane (MPTS). This coating 
has a nanoscale rod-like topography as shown in Figure 5.1. Together the microstructures, 
nanostructures and the low surface energy produce a superhydrophobic surface on Mg AZ31 
[20]. Their study further demonstrated that the superhydrophobic Mg AZ31 surface was resistant 
to corrosion in 3.5% NaCl solution [20]. 
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Figure 5.1: AFM Image of a Mixed MPTS/PDMS Coating on Magnesium Surface. 
(Adapted from [20]) 
Although superhydrophobic surfaces decrease the rapid degradation of magnesium 
alloys, the interaction between the cells and the implant surfaces is also reduced leading to a 
decrease in the ability of the implant to induce bone regeneration and, therefore, limiting its 
biocompatibility. 
Mimicking the structure and chemical composition of the extracellular matrix (ECM) 
through the attachment of ECM proteins has been shown to improve the biocompatibility of 
implant surfaces [21]. Cells bind to biomaterials surface through ligands found in proteins of the 
extracellular matrix. Integrins on the cell membrane interact with extracellular matrix (ECM) 
proteins such as fibronectin, laminin, and vitronectin through specific ligands. Fibronectin 
protein plays a very important role in cell attachment to substrate [22]. The arginylglycylaspartic 
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acid (RGD) amino acid sequence, which is commonly found in the cell adhesive protein 
fibronectin, is an essential recognition site for integrins on the cell membrane supporting cell 
adhesion and proliferation at biomaterials surfaces [21]. The attachment of the RGD peptide 
sequence to biomaterial surfaces has been shown to significantly improve osteoblast adhesion 
and proliferation on various implant surface such as titanium, polymers, and magnesium alloys 
[23,24,25].  
A simple surface modification procedure was employed in this study to attach a 
fibronectin mimic to the surface of the superhydrophobic Mg AZ31 surface. This method 
involved immobilization of MAPTrix-F-RGD, a mussel adhesive protein containing the RGD 
sequence to the surface. Mussel adhesive proteins (MAPs) are a natural “glue” that has been 
shown to strongly adhere to virtually any material. They are generally rich in 3,4-
dihydryoxyphenylalanine (DOPA) that has a catechol functional group that is believed to impart 
the strong adhesion characteristic of these proteins [26]. MAPs have been successfully coated 
onto a variety of material surface via one-step procedures such as deposition, precipitation or 
spin coating [26,27]. The mussel adhesive protein used in this study, MAPTrix-F-RGD, is a 
commercially available mussel adhesive protein that has been shown to enhance cell adhesion 
and proliferation on some substrates [28,29].  
The objective of this study was to develop a method for the immobilization of the 
MAPTrix-F-RGD protein to the superhydrophobic Mg AZ31. In addition, the influence of this 
surface modification on Saos-2 osteoblast adhesion to the modified surfaces in comparison to 
unmodified superhydrophobic surfaces was determined using the CyQuant assay.  
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5.2 Material and Methods  
5.2.1 Materials 
  Mg AZ31 foil (0.81 mm thickness) was purchased from Alfa Aesar Ltd (US). Sodium 
hydroxide was purchased from Sigma-Aldrich (Canada). Acetone (reagent grade) was purchased 
from Caledon Laboratory Chemicals (Canada). Ethyl alcohol (95%) and methanol were 
purchased from Commercial Alcohols (Canada). Concentrated sulphuric acid was purchased 
from Fisher Chemical LTD. 30% hydrogen peroxide, 3-mercaptopropyltrimethoxysilane 
(MPTS), poly(dimethylsiloxane) (PDMS) and MAPTrix-F-RGD were purchased from Sigma 
Aldrich Ltd. Bovine Calf Serum (BCS) and Trypan Blue were purchased from Fisher Scientific 
(Canada). McCoy’s 5a and Trypsin/EDTA (1X) were purchased from Corning (Canada). 
Phosphate Buffered Saline (PBS) (1X) and Penicillin-Streptomycin Solution were purchased 
from HyClone (Canada). The CyQUANT cell proliferation assay was purchased from Life 
Technologies (Canada). All chemicals were used as received without further purification. The 
Saos-2 cell line was purchased from American Type Culture Collection (US) and cultured for 
further experiments. 
5.2.2 Sample Preparation 
Mg AZ31 alloy sheet (0.81 mm thickness) was cut into circular discs with a diameter of 
1.27 cm and then polished to a 9 micron surface finish to remove the gross oxide layer. In order 
to clean and remove any excess polishing oil from the surface of the alloys, they were sonicated 
in acetone for 20 minutes and then rinsed in deionized water for 30 seconds.  
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5.2.3 Preparation of Superhydrophobic Magnesium Surfaces 
 Two-step Etching Procedure 
A two-step etching procedure was employed to produce the microstructure of the 
superhydrophobic surface. In the first step the polished magnesium AZ31 sample was immersed 
into 20 mL of a 2% (v/v) H2SO4 solution for 4 minutes at 80ºC with sonication. In the second 
step the samples were immersed into 20 mL of a 20% (v/v) H2O2 solution with sonication for 2.5 
minutes at 80ºC. The etched samples were rinsed with copious amounts of deionized water and 
air-dried. 
 Polysiloxane Coating 
The coating solution was prepared by mixing MPTS: PDMS in a molar ratio of 100:1. 
First of all, a 1% MPTS solution was prepared by mixing 1 mL of MPTS (in methanol) with 
0.484 mL of deionized water. The solution was adjusted to pH 4 using 0.05 M H2SO4. The pH 
adjusted solution was stirred for 90 minutes at room temperature to promote hydrolysis of the 
MPTS molecules. Then, 31 µL of PDMS was added to the 1% MPTS solution. The polysiloxane 
solution was allowed to stir for 24 hours to allow condensation between the hydrolyzed MPTS 
and the hydroxyl terminated PDMS molecules prior to coating. Then the etched samples were 
deposited in the coating solution for 24 hours at 50 ºC. After coating, the samples were dried 
before curing in an oven for 1h at 100 °C. 
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5.2.4 Deposition of MAPTrix-F-RGD Protein 
The MAPTrix-F-RGD protein was deposited using two different methods: 
Method 1. The as received MAPTrix-F-RGD solution was diluted in a 50 mM sodium 
bicarbonate buffer solution at pH 8.5. Then, 600 µL of the diluted protein solution (0.25 mg/mL) 
was deposited onto the superhydrophobic Mg AZ31 samples and they were incubated at 37 °C 
for 3 hours. At the end of the 3 hours, the alloys were rinsed with deionized water and air-dried. 
Method 2. The MAPTrix-F-RGD solution was diluted using a methanol: deionized water 
mixture in a 2:3 volume ratio. Then, 300 µL of the diluted protein solution (0.25 mg/mL) was 
deposited onto a superhydrophobic Mg AZ31 sample and they were incubated at 37 °C overnight 
until the liquid evaporated completely. The samples were then rinsed with deionized water and 
air-dried. 
5.2.5 Surface Characterization 
 ATR-FTIR Microscopy 
Attenuated Total Reflection Fourier Transform Infrared microscopy (ATR-FTIR) was 
used to analyze the surface chemistry of the samples. A Bruker Optics Hyperion infrared 
microscope with an attenuated total reflectance objective and a germanium crystal was 
employed. The resolution of the spectrometer was 4 cm−1 and 100 scans were taken per 
spectrum. The baseline and atmospheric compensation function of the OPUS software was used 
to correct all spectra. Spectra were collected in a minimum of three spots per sample. 
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 Contact Angle Analysis 
Contact angle goniometry was used to evaluate the wettability of the surfaces after each 
stage of the surface modification. A PG-2 Pocket Goniometer was used to determine the static 
contact angles with 6 µL of purified 18 MΩ water. Each data point represents an average of 6 
samples; the error bars are the sample to sample standard deviations. 
 Scanning Electron Microscopy and Energy Dispersive X-ray 
Spectroscopy (SEM-EDS) 
Scanning electron microscopy and energy dispersive X-ray spectroscopy (SEM-EDS) 
were used to evaluate the surface morphology of the superhydrophobic surface. SEM images 
were obtained using a JEOL 6400 field emission SEM operated at 20kV, 1 nA and 10-6 Torr. An 
Oxford EDS detector was used to determine the elemental composition of the sample surface. 
Samples to be analyzed were coated with a thin film of carbon to render the sample conductive. 
5.2.6 Cell Culture   
Saos-2 cells were cultured in McCoy’s 5a cell culture medium containing 15% Bovine 
Calf Serum and 1% penicillin/streptomycin at 37oC in a 5% CO2 atmosphere. The cell culture 
medium was changed every two days. Once the cells grew to about 70-80% confluence, the cells 
were washed with PBS and detached from the flask with Trypsin/EDTA and then centrifuged at 
2500 rpm for 5 minutes. The supernatant was discarded, and the cells were resuspended in fresh 
McCoy’s medium. The number of cells in the suspension was determined by the trypan blue dye 
using a Neubauer hemocytometer.  
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5.2.7 Cell Adhesion Test   
All samples were sterilized in 70% ethanol before the adhesion experiment, and then 
rinsed with warm, sterile PBS. The samples were then placed in the wells of a 24-well plate. In 
order to evaluate the adhesion of cells on the superhydrophobic Mg AZ31, 40,000 cells in 2 mL 
of McCoy’s medium were allowed to adhere on the substrates for 3 hours at 37oC in a 5% CO2 
atmosphere. After the incubation period, the Mg alloys were rinsed with warm PBS in order to 
remove nonadherent cells, then stored at -20ºC overnight for the cells to lyse. Later, the cell 
number was determined using the CyQUANT assay, following the manufacturer’s instructions. 
Briefly, 200 µL of CyQUANT solution was added to each sample and incubated for 5 minutes. 
At the end of the incubation period, 100 µL of the CyQUANT solution was pipetted from each 
well to a black fluorescent 96-well plate (Costar) and the fluorescence intensity of each solution 
was measured with a Fluostar Optima spectrofluorometer. The cell number was then determined 
using a calibration curve of cell number vs. fluorescence intensity. In addition, cells grown on 
the bare well surface were applied as a positive control group. The experiment was repeated two 
times on different days to ensure the reliability of the results. Each individual experiment 
consisted of 3 superhydrophobic samples, 3 MAPTrix-F-RGD modified superhydrophobic 
samples and 3 positive controls.  
165 
 
 
 
5.3 Results and Discussion 
5.3.1 Characterization of Superhydrophobic Surfaces 
In order to ensure the successful production of the superhydrophobic Mg AZ31 surface, 
ATR-FTIR spectroscopy and contact angle analysis were performed to characterize the surface 
of the samples after each step of the surface modification procedure. 
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Figure 5.2: Infrared Spectra of Mg Alloy before and after Etching. (a) Polished and 
(b) Etched Samples. 
ATR-FTIR spectroscopy was employed to confirm the surface chemistry of the 
magnesium alloys after each modification. Figure 5.2 shows the ATR-FTIR spectra of the Mg 
AZ31 samples after polished and etching. The spectrum of the polished magnesium alloy shows 
a small peak at 3750 cm-1 which indicates the presence of Mg(OH)2 and a broad peak (3080-
(b) 
(a) 
167 
 
 
 
3460 cm-1) from the O-H stretch of adsorbed water at the surface. The spectrum of magnesium 
after the two-step etching process shows a broad carbonate stretch band centered at 1400 cm-1 
due to the reaction of the magnesium surface with the carbon dioxide in the atmosphere. In 
addition, a peak at 1100 cm-1 was observed. The peak is due to the presence of sulphate (SO4
2-) 
at the surface and indicates the formation of magnesium sulphate during etching in sulphuric 
acid.  
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Figure 5.3: Infrared Spectrum of Hydrophobic Polysiloxane Coating on Polished 
Magnesium Alloys. 
The deposition of a hydrophobic layer on the top of the rough surface is a very important 
step to produce a superhydrophobic surface. A hydrophobic polysiloxane layer was deposited by 
using MPTS and PDMS as both of these compounds are hydrophobic. MPTS was present as a 
linker molecule to bind the polysiloxane layer to the magnesium alloy surface. After hydrolysis 
Si-O 
Si-C 
CH2/CH3 
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of the MPTS molecules, a condensation reaction between the terminal hydroxyl groups on the 
PDMS molecules and the silanol groups of MPTS will occur to link the two hydrophobic 
compounds together. Then, by further condensation of the silanol of MPTS with hydroxyl groups 
on the magnesium alloy surface, the polysiloxane layer will covalently bond to the surface of 
magnesium. Figure 5.3 shows the ATR-FTIR spectra of the hydrophobic polysiloxane coating 
deposited on the polished magnesium alloy. There are three peaks that confirm the presence of 
the polysiloxane coating on the surface of the polished magnesium alloy sample. The first is the 
(Si-O-Si) peak at 1050-1200 cm-1 which indicates the presence of silicate. The second is the (Si-
CH3) peak at 1260 cm
-1 which confirms the polymerization of MPTS with PDMS. The third is 
the (C-H) stretch at 2850-3000 cm-1 which confirms the presence of the alkyl functional groups 
of the MPTS and PDMS molecules. These three peaks were preferred for confirming the 
presence of the hydrophobic siloxane coating on the sample surfaces as there is no interference 
from peaks due to the polished and etched substrates.  
170 
 
 
 
4000 3500 3000 2500 2000 1500 1000
0.00
0.05
0.10
In
te
n
si
ty
 (
a.
u
.)
Wavenumbers (cm
-1
)
 
Figure 5.4: Infrared Spectrum of Superhydrophobic Surface of Magnesium Alloys 
In order to produce a superhydrophobic surface, it is necessary to have a combination of 
surface roughness and hydrophobic surface chemistry.  Figure 5.4 shows an ATR-FTIR spectrum 
of the superhydrophobic surface produced by depositing a hydrophobic polysiloxane layer on the 
etched magnesium alloy surface. The presence of Si-O-Si, Si-CH3 and C-H stretch peaks in the 
spectrum indicate the successful deposition of the hydrophobic polysiloxane coating on the 
etched magnesium alloys.    
Si-O 
Si-C CH2/CH3 
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Figure 5.5: Images of Geometric Water Contact Angles of (a) Polished Surface, (b) Etched 
Surface, (c) Polysiloxane Coating on Polished Surface, and (d) Polysiloxane Coating on 
Etched Surface (Superhydrophobic Surface). 
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Figure 5.6: Water Contact Angle Measurements of (a) Polished Surface, (b) Etched 
Surface, (c) Polysiloxane Coating on Polished Surface, and (d) Polysiloxane Coating on 
Etched Surface. Each Data Point Represents an Average of 6 Samples; the Error Bars are the 
Sample to Sample Standard Deviations. 
To evaluate the wettability of the surface, contact angle analysis was performed after 
each step of the surface modification procedure. Figure 5.5 and Figure 5.6 show the images of 
the water droplets and the measured contact angles alloys after each step of the 
superhydrophobic surface modification procedure. The contact angle of the polished magnesium 
substrates was (55.8°±4.3°), indicating that the polished and cleaned Mg AZ31 surfaces were 
slightly hydrophilic while the etched surfaces were very hydrophilic with low contact angles 
(11.2°± 3.0°) due to the surface roughness produced during acid etching. The contact angle of 
the polysiloxane coating on apolished magnesium alloys was (91.4°± 7.1°) indicating a slightly 
hydrophobic surface due to the hydrophobic nature of the MPTS and PDMS molecules.  
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To produce a superhydrophobic surface, a combination of a rough surface topography 
with a hydrophobic surface chemistry is needed. Combining both the etched surface and the 
hydrophobic polysiloxane coating produced a superhydrophobic surface on magnesium alloys 
that is confirmed by its high contact angle of 150.0°± 5.9°.  
 
Figure 5.7: SEM Images of the Superhydrophobic Surface of Magnesium Alloy at Different 
Magnifications. (a) Full Superhydrophobic Surface at Low Magnification 500μm, (b) Full 
Surface at High Magnification with a Scale of 50μm (c) Flat Area at High Magnification with a 
Scale of 10μm (d) Spherical Particles at High Magnification with a scale of 10μm. 
a 
b 
d c 
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The topography of the etched surface was observed using SEM microscopy. Figure 3.7 
shows the SEM images of the etched magnesium alloy surface at different magnifications. The 
surface image in Figure 5.7 (a) shows randomly distributed spherical particles over the whole 
surface. At higher magnification image (b), it is evident that the size of these spherical particles 
is approximately 25 μm diameter. These protrusions provided the microstructures that are 
necessary to mimic the superhydrophobic surface of the lotus leaf. Also, at high magnification 
image (c) of the flat area, it is clear that there are cracks on the flat area of the surface. Moreover, 
image (d) shows the spherical particles at higher magnification; this image shows that the micro-
scale particles are composed of smaller particles of variable size. This set of images illustrates 
the complex topography produced by the etching process. In addition, Figure 5.1 showed that 
when the polysiloxane coating was added an additional nanoscale rod like topography was added 
to the surface. 
5.3.2 Deposition of MAPTrix-F-RGD Protein on the Superhydrophobic 
Surface 
The previous section of this study confirmed the successful reproducibility of the 
superhydrophobic surface. In order to improve the biocompatibility of the superhydrophobic 
surface, further surface modification by immobilization of the cell adhesive molecule MAPTrix-
F-RGD protein was employed. The presence of the RGD peptide in this MAPTrix-F-RGD 
protein should help to mimic the extracellular matrix. The RGD sequence is a well-known 
unique amino acid sequence that can be specifically recognized by integrins on the cell 
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membrane thus supporting cell adhesion and proliferation at biomaterials surfaces [21]. In order 
to optimize the best deposition conditions for the immobilization of the MAPTrix-F-RGD 
protein on the superhydrophobic surfaces, two different methods were tested as described in 
section 5.2.4. The modified samples were analyzed by infrared microscopy and contact angle 
analysis to confirm the deposition of the MAPTrix-F-RGD protein on the superhydrophobic 
surface. 
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 Deposition of MAPTrix-F-RGD Protein Using Sodium Bicarbonate 
Solution 
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Figure 5.8: Infrared Spectra of MAPTrix-F-RGD Protein Deposited on Superhydrophobic 
Surface Using Sodium Bicarbonate Solution and Various Concentration of MAPTrix-F-
RGD Protein. (a) Superhydrophobic Surface and after Deposition of (b) 0.1 mg mL-1 and (c) 
0.25 mg mL-1 of MAPTrix-F-RGD Protein for 3 hours Deposition Time.  
(c) 
(a) 
(b) 
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Figure 5.9: Partial Infrared Spectra of Superhydrophobic Surface before and after 
Deposition of MAPTrix-F-RGD Protein. (a) Superhydrophobic Surface and after Deposition 
of (b) 0.1 mg mL-1 and (c) 0.25 mg mL-1 of MAPTrix-F-RGD Protein for 3 hours Deposition 
Time. 
Figure 5.8 and Figure 5.9 show the ATR-FTIR spectra of superhydrophobic surfaces of 
magnesium alloys before and after deposited MAPTrix-F-RGD protein with various 
concentrations using sodium bicarbonate solution as the solvent. MAPTrix-F-RGD is a protein 
and therefore it can be identified by the presence of the amide I (C=O stretch at 1650 cm-1) and 
amide II (N-H bend at 1500 cm-1). The spectra of the superhydrophobic surfaces after deposition 
of MAPTrix-F-RGD protein (0.1 mg mL-1 and 0.25 mg mL-1) are similar to those of the 
unmodified superhydrophobic surface. A slight shift of the peak at 1610 cm-1 to 1650 cm-1 was 
observed which could be related to the presence of the amide I band of the protein. The 
(b) 
(c) 
(a) 
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differences subtle in the spectra due to overlapping peaks from the superhydrophobic surface 
itself. However, the contact angle measurements after modification with MAPTrix-F-RGD 
dropped from 150.03° ± 5.90° to 26.36°± 7.31° and 27.24°± 4.3° for samples modified with 0.1 
mg mL-1 and 0.25 mg mL-1 MAPTrix-F-RGD respectively.  
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Figure 5.10: Infrared Spectra of MAPTrix-F-RGD Protein Deposited on 
Superhydrophobic Surface Using Sodium Bicarbonate Solution at Concentration of 0.25 
mg mL-1 and Various Deposition Time. (a) Superhydrophobic Surface and (b, c) after 1 and 3 
hours of Deposition MAPTrix-F-RGD Protein. 
(a) 
(c) 
(b) 
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Figure 5.11: Partial Infrared Spectra of Superhydrophobic Surface before and after 
Deposition of MAPTrix-F-RGD Protein. (a) Superhydrophobic Surface and (b, c) after 1 and 3 
hours of Deposition MAPTrix-F-RGD Protein. 
Figure 5.10 and Figure 5.11 show the ATR-FTIR spectra of superhydrophobic surfaces of 
magnesium alloys before and after deposited MAPTrix-F-RGD protein using sodium bicarbonate 
solution at concentration of 0.25 mg mL-1 and various deposition time. The spectra of the 
superhydrophobic surfaces after 1 and 3 hours of MAPTrix-F-RGD protein deposition are 
similar to those of the unmodified superhydrophobic surface. There is only a slight shift of the 
peak from 1610 cm-1 peak to 1650 cm-1 was observed which could be related to the presence of 
the amide I band of the protein.  
(a) 
(b) 
(c) 
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 Deposition of MAPTrix-F-RGD Protein Using the Mixture of 
Methanol and Water Solution 
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Figure 5.12: Partial Infrared Spectra of MAPTrix-F-RGD Protein Deposited on 
Superhydrophobic Surface of Magnesium Alloys Using a Methanol/Water Solution. (a) 
Superhydrophobic Surface and (b) after Deposition of MAPTrix-F-RGD Protein. 
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Figure 5.13: Infrared Spectra of MAPTrix-F-RGD Protein Deposited on 
Superhydrophobic Surface of Magnesium Alloys Using a Methanol/Water Solvent. (a) 
Superhydrophobic Surface and (b) after Deposition of MAPTrix-F-RGD Protein. 
Figure 5.12 shows the partial ATR-FTIR spectra of MAPTrix-F-RGD protein deposited 
on superhydrophobic surface of magnesium alloys using the mixture of methanol and water as a 
solvent (0.25 mg mL-1 of MAPTrix-F-RGD). The spectrum of the superhydrophobic surface 
(a) 
(b) 
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after deposition of MAPTrix-F-RGD (b) shows a new peak at 1515 cm-1 which indicates the 
presence of amide II band (N-H stretch). Despite overlapping with adsorbed water peak (O-H), 
the amide I peak at 1650 cm-1 was clearly observed and the peak becomes sharper than before 
modification. Therefore, these observations confirm the successful deposition of MAPTrix-F-
RGD protein on the superhydrophobic surface using the mixture of methanol and water as a 
solvent.  
Figure 5.13 shows the whole ATR-FTIR spectra of MAPTrix-F-RGD protein deposited 
on superhydrophobic surface of magnesium alloys using the mixture of methanol and water as a 
solvent in comparison to superhydrophobic surface before modification. It is clear from the 
whole spectrum that all peaks indicating the presence of the polysiloxane coating are still present 
after the deposition of the Maptrix-F-RGD protein. Thus, the methanol/water solvent had no 
impact on the underlying polysiloxane coating.   
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Figure 5.14: Images of Geometric Water Contact Angles of (a) Superhydrophobic Surface 
and (b) MAPTrix-F-RGD Modified Superhydrophobic Surface Using a Methanol/water 
Mixture as Solvent. 
The influence of the MAPTrix-F-RGD protein on the wettability of the superhydrophobic 
surface was evaluated by contact angle analysis. Figure 5.14 shows water droplets on the 
superhydrophobic surface of magnesium alloys before and after deposition of MAPTrix-F-RGD 
protein. A significant change in the water contact angle from 150.0°± 5.9° to 39.3o ± 5 indicates 
that the surface was successfully modified through MAPTrix-F-RGD protein and that the 
presence of the protein increased the hydrophilicity of the surface.  
5.3.3 Evaluation of the Biocompatibility of MAPTrix-F-RGD Protein 
Deposited on Superhydrophobic Surface of Magnesium Alloy AZ31 
While superhydrophobic surfaces decrease the rapid degradation of magnesium alloys, 
the interaction between the cells and the superhydrophobic surface is also reduced leading to 
poor cell adhesion and limited biocompatibility. It is well known that hydrophilic surfaces 
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typically enhance cell adhesion on biomaterials [30]. A study by Lim et al. observed that the 
osteoblastic cells exhibited greater adhesion and proliferation on hydrophilic surfaces than on 
hydrophobic surfaces [30]. Therefore, it was expected that the presence of the RGD ligand 
coupled with the improved wettability of the surface would lead to improved cell adhesion for 
the MAPTrix-F-RGD modified superhydrophobic surfaces in comparison to the unmodified 
superhydrophobic surfaces. This is important because cell adhesion on biomaterials surfaces is 
an essential step for evaluating the biocompatibility of implants to ensure successful 
ossteoconduction and osseointegration of the implant with bone tissue [31]. In particular, a study 
performed in our lab by Yang et al. demonstrated successful adhesion and proliferation of 
SAOS-2 cells on a magnesium alloy surface through the covalent attachment of RGD peptides. 
The biocompatibility of MAPTrix-F-RGD modified superhydrophobic surfaces was 
evaluated by comparing the number of cells adhered on the modified surface versus the 
superhydrophobic control sample. 
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Figure 5.15: Cell Numbers of (Saos-2 Cell) Adhered on Superhydrophobic Surface before 
and after Deposition of MAPTrix-F-RGD Protein using Sodium Bicarbonate Solution. The 
Data are the Average of 3 Replicates and the Experiment was Repeated Two Times to Ensure 
Reproducibility.  
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Figure 5.16: Cell Numbers of (Saos-2 Cell) Adhered on Superhydrophobic Surface before 
and after Deposition of MAPTrix-F-RGD Protein using the Mixture of Methanol and 
Water Solution. The Data are the Average of 3 Replicates and the Experiment was Repeated 
Two Times to Ensure Reproducibility. 
Figure 5.15 shows the number of Saos-2 cells adhered on the superhydrophobic surface 
before and after deposition of MAPTrix-F-RGD from a sodium bicarbonate solution and Figure 
5.16 shows the number of Saos-2 cell adhered on the superhydrophobic surface before and after 
deposition of MAPTrix-F-RGD protein from a methanol/water mixture. Cells grown on the bare 
well surface (No Mg alloy) was applied as a positive control group.  
Also, a preliminary study was performed for MAPTrix-F-RGD protein deposited on the 
well surface to investigate the cell adhesion capability of this molecule in the absence of 
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superhydrophobic and modified superhydrophobic magnesium alloys. The results were positive 
and indicated that cells readily adhered to these surfaces.  
As observed in Figure 5.15 and Figure 5.16, the average number of cells adhered to the 
modified superhydrophobic surface is similar to the average number of cells adhered to the 
superhydrophobic surface. Although, infrared spectroscopy confirmed that the cell adhesive 
molecule was successfully immobilized to the surface and that the surface wettability was greatly 
improved, cell adhesion was not improved on the MAPTrix-F-RGD modified superhydrophobic 
samples.  Possible reasons for this behaviour are discussed below. 
It is well known that morphology, wettability, topography, and chemical composition of a 
biomaterial surface all have a strong influence on cell behavior [32]. However, the influence of 
surface properties on cell behavior is still not fully understood. Many scientists have debated the 
roles of various surface properties on the cell adhesion efficiency due to the complex relationship 
between these properties. For example, hydrophilic surfaces are generally known to have a 
higher affinity for cells while superhydrophobic surfaces have been generally reported to prevent 
cell adhesion. Dowling et al. reported that the adhesion and proliferation of osteoblast cells were 
prevented on superhydrophobic surfaces [33]. However, in another study, Zangi et al. 
synthesized superhydrophobic surfaces with microscale and nanoscale features; they found that 
the sample with a micro-scale rough structure and superhydrophobic behavior accelerated cell 
attachment and proliferation while the sample with a nano-scale rough structure and 
superhydrophobic behavior strongly inhibited cell adhesion [34]. Therefore, it was concluded 
from this study that surface topography plays a more significant role in cell adhesion than 
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superhydrophobicity [34]. In contrast, other studies have suggested that micro-scale surface 
topography enhances the anti-adhesive properties of the implant material surface since it 
significantly reduced the adhesion of macrophages and fibroblast cells [35,36]. 
Therefore, our results and the inhibition of cell adhesion on both the superhydrophobic 
surface and the MAPTrix-F-RGD modified superhydrophobic surface may be attributed to the 
topography of the superhydrophobic surface. The superhydrophobic magnesium surface prepared 
in this study has a hierarchical surface topography consisting of micron scale papillae produced 
during etching (approximately 25 μm diameter spherical particles) and a nanoscale rod like 
structure from the polysiloxane overcoating. Many studies have demonstrated that nano-scale 
topography can inhibit or reduce cell adhesion [34,37]. This inhibition has been attributed to the 
amount and the conformation of the protein adsorbed on the surface [38].  
In addition, the height of the micron scale particles present on the superhydrophobic 
surface, may be an obstacle to cell adhesion and spreading because they are on the order of the 
cell size. Many studies have also reported that micro-scale topographies with different shapes, 
sizes, heights and surface distribution can affect cell adhesion [35,36]. This effect can be either 
positive or negative, some studies have shown that micron scale topographies enhance cell 
adhesion [34,37,39]. However, the effect of topography is very complex with cell behavior being 
dependent on the type, size, height and regularity of the feature and also the cell size and type. 
Le Saux et al. synthesised surfaces that had topographical features with various pyramids height, 
RGD ligands were immobilized on these surfaces to study the effect of these topographical 
features on cell adhesion. The cell behaviour results after immobilization of RGD ligands on 
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these surfaces demonstrated that surfaces with micro-scaled pyramids, which had the highest 
height values, reduced the cell adhesion compared to flat surfaces. Furthermore, although it is 
known that the RGD ligands influence cell behavior, the presence of RGD ligands on their micro 
scale surfaces did not enhance the cell adhesion [40]. 
Accordingly, on the surfaces prepared in this study, the nano-scale particles coupled with 
the large height of the micro-scale particles and their overall surface distribution may be the 
reasons that cell adhesion is inhibited on the MAPTrix-F-RGD modified superhydrophobic 
surface despite its known cell adhesive properties and the improved wettability of our modified 
surfaces. Changes to the surface etching procedure may be an option to control this topography 
to give microscale particles with smaller height; this may lead to an improvement in cell 
adhesion on the modified superhydrophobic surface. 
5.4 Conclusion 
In this study, a superhydrophobic Mg AZ31 surface was successfully reproduced through 
a combination of rough hierarchical topography and a hydrophobic overlayer. It is well-known 
that superhydrophobic surfaces reduce the interaction between the cell and the surface. 
Therefore, a simple method for modifying the superhydrophobic surface was employed to mimic 
the extracellular matrix (ECM). The superhydrophobic surface was successfully modified with 
cell adhesive MAPTrix-F-RGD protein. However, the results from the cell adhesion test 
demonstrated that MAPTrix-F-RGD protein on the superhydrophobic surface did not improve 
the cell adhesion to the superhydrophobic surfaces. This is likely due the complex topography of 
the surface.  
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Chapter 6  
6 Conclusions and Future Directions 
The objective of the first project was to demonstrate the applicability of the cyanine dye 
for the in vitro evaluation of the biocompatibility of biodegradable magnesium materials by both 
direct and indirect methods. This study demonstrates a quick and reliable assay to evaluate the 
biocompatibility of biodegradable magnesium alloys by both direct and indirect methods. The 
CyQUANT assay provides a more accurate assessment of the overall in vitro biocompatibility of 
biodegradable metals than the more commonly used assays that are depending on chemical 
reduction. Upon comparison of the direct and indirect methods, it is evident these two techniques 
provide complementary information. In the case of the direct method, it was observed that the 
cells were able to adhere to the surface of Mg AZ31, which would not have been possible using 
an indirect assay. On the other hand, the magnesium-conditioned medium was shown to be only 
slightly toxic to the cells using the indirect method. Therefore, the indirect method can be used to 
quantify the cytotoxicity of the magnesium alloys while the direct method can be used to 
measure the cell adhesion and proliferation. The results of the direct and indirect methods 
indicate that in order to accurately determine the cytotoxicity as well as the biocompatibility of 
biodegradable magnesium alloys, different factors such as the rapid pH change, hydrogen gas 
produced and deposition of biodegradation products during biocorrosion process must be taken 
into consideration. 
The objective of the second project was to develop a surface modification strategy for 
magnesium alloys that controls both the degradation rate and the biocompatibility of these 
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materials. A multi-layered coating consisting of a sol-gel silica layer, a mesoporous silica layer 
and a layer of calcium phosphate was successfully deposited on magnesium alloy AZ31. The in 
vitro biodegradation test in physiological solutions (SBF) established that the multi-layer coating 
provides an excellent protection for the magnesium alloy substrate from rapid degradation. 
Moreover, the in vitro cell studies indicated the cytocompatibility of the multi-layered coating. 
These in vitro studies confirm that these multi-layered coatings are an effective surface 
modification strategy for controlling both the degradation rate and biocompatibility of 
magnesium alloys for medical applications in bone repair. Furthermore, longer investigation time 
of in vitro degradation studies are needed in this study to determine the bioactivity and 
degradation behaviour of brushite layer in simulated body fluid. Moreover, in vitro cell adhesion 
and proliferation studies are needed to have a more accurate assessment of the biocompatibility 
of the coating.  
The objective of the third project was to prdevelop a method for the immobilization of 
the MAPTrix-F-RGD protein to the superhydrophobic Mg AZ31 and to study the influence of 
this surface modification on Saos-2 osteoblast adhesion to the modified surfaces in comparison 
to unmodified superhydrophobic surfaces. A superhydrophobic Mg AZ31 surface was 
successfully reproduced through a combination of rough hierarchical topography and a 
hydrophobic overlayer. A superhydrophobic magnesium alloy surface was successfully modified 
with a fibronectin mimetic cell adhesive MAPTrix-F-RGD protein using the mixture of methanol 
and water solution. However, the in vitro cell adhesion results demonstrated that MAPTrix-F-
RGD protein on the superhydrophobic surface did not enhance the cell adhesion of 
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superhydrophobic surfaces probability due to the complex topography of the superhydrophobic 
surface. The nano-scale particles coupled with the large height of the microscale particles and 
their distribution on the surface may be the reasons that cell adhesion is inhibited on the 
MAPTrix-F-RGD modified superhydrophobic surface. Therefore, further experiments are 
required to explain the effect of the complex micro and nano scale topography of the 
superhydrophobic magnesium alloy surface on cell adhesion. The cell adhesion should be 
evaluated on smooth surfaces with the same surface chemistry as the superhydrophobic surfaces 
with and without MATRrix-F-RGD.  In addition, etched surfaces without the nanoscale coating 
before and after addition of MAPTrix-F-RGD should be evaluated to determine if the anti-
adhesive effect is due to the microscale features alone.  Finally, surfaces with microscale 
particles of variable height and surface distribution should also be analyzed for their cell 
adhesive properties with and without the cell adhesive ligand. 
In general, it is recommended that for studies involving magnesium alloys as a 
biomaterial, the structure, composition and morphology of the coated surface must always be 
considered to achieve stable, anti-corrosion and biocompatible magnesium implants. Combining 
nano-and micro-textures to mimic the hierarchical structure of bone tissue should be taken into 
account to improve the integrity at the bone/implant interface. Surface roughness is an important 
factor in cell attachment and corrosion behaviours of magnesium and its alloys but more research 
is needed in this area. Therefore, the effect of the surface roughness of magnesium and its alloys 
on the degradation rate and cell behavior should be widely studied under in vitro and in vivo 
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conditions. Besides the surface roughness, the effect of surface morphology and porosity on the 
corrosion behaviors of magnesium in vivo has not been fully investigated. 
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